{"markup":"\u003C?xml version=\u00221.0\u0022 encoding=\u0022UTF-8\u0022 ?\u003E\n    \u003Chtml version=\u0022HTML+RDFa+MathML 1.1\u0022\n    xmlns:content=\u0022http:\/\/purl.org\/rss\/1.0\/modules\/content\/\u0022\n    xmlns:dc=\u0022http:\/\/purl.org\/dc\/terms\/\u0022\n    xmlns:foaf=\u0022http:\/\/xmlns.com\/foaf\/0.1\/\u0022\n    xmlns:og=\u0022http:\/\/ogp.me\/ns#\u0022\n    xmlns:rdfs=\u0022http:\/\/www.w3.org\/2000\/01\/rdf-schema#\u0022\n    xmlns:sioc=\u0022http:\/\/rdfs.org\/sioc\/ns#\u0022\n    xmlns:sioct=\u0022http:\/\/rdfs.org\/sioc\/types#\u0022\n    xmlns:skos=\u0022http:\/\/www.w3.org\/2004\/02\/skos\/core#\u0022\n    xmlns:xsd=\u0022http:\/\/www.w3.org\/2001\/XMLSchema#\u0022\n    xmlns:mml=\u0022http:\/\/www.w3.org\/1998\/Math\/MathML\u0022\u003E\n  \u003Chead\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_YjAJQgxDlFX6S-O02jj9jCrVbrwlY3CGgCg1FzPlvBs.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nif(typeof window.MathJax === \u0022undefined\u0022) window.MathJax = { menuSettings: { zoom: \u0022Click\u0022 } };\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_waP91NpgGpectm_6Y2XDEauLJ8WCSCBKmmA87unpp2E.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.googletagmanager.com\/gtag\/js?id=G-0K57TCX5BY\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nwindow.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag(\u0022js\u0022, new Date());gtag(\u0022set\u0022, \u0022developer_id.dMDhkMT\u0022, true);gtag(\u0022config\u0022, \u0022G-0K57TCX5BY\u0022, {\u0022groups\u0022:\u0022default\u0022,\u0022anonymize_ip\u0022:true});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\njQuery.extend(Drupal.settings, {\u0022basePath\u0022:\u0022\\\/\u0022,\u0022pathPrefix\u0022:\u0022\u0022,\u0022highwire\u0022:{\u0022ac\u0022:{\u0022medrxiv;2025.02.17.25321289v1\u0022:{\u0022access\u0022:{\u0022full\u0022:true},\u0022pisa_id\u0022:\u0022medrxiv;2025.02.17.25321289v1\u0022,\u0022apath\u0022:\u0022\u0022,\u0022jcode\u0022:\u0022medrxiv\u0022}},\u0022processed\u0022:[\u0022highwire_math\u0022],\u0022markup\u0022:[{\u0022requested\u0022:\u0022full-text\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022medrxiv;2025.02.17.25321289v1\u0022}]},\u0022instances\u0022:\u0022{\\u0022highwire_abstract_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:20,\\u0022height\\u0022:20,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-abstract-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022right center\\u0022,\\u0022my\\u0022:\\u0022left center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022shift\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter click \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_author_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-author-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022top center\\u0022,\\u0022my\\u0022:\\u0022bottom center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_reflinks_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022mimic\\u0022:\\u0022top center\\u0022,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-ref-link-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022bottom left\\u0022,\\u0022my\\u0022:\\u0022top left\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022flip\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}}}\u0022,\u0022qtipDebug\u0022:\u0022{\\u0022leaveElement\\u0022:0}\u0022,\u0022googleanalytics\u0022:{\u0022account\u0022:[\u0022G-0K57TCX5BY\u0022],\u0022trackOutbound\u0022:1,\u0022trackMailto\u0022:1,\u0022trackDownload\u0022:1,\u0022trackDownloadExtensions\u0022:\u00227z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip\u0022,\u0022trackColorbox\u0022:1},\u0022ajaxPageState\u0022:{\u0022js\u0022:{\u0022\\\/\\\/cdn.jsdelivr.net\\\/qtip2\\\/2.2.1\\\/jquery.qtip.min.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_article_reference_popup.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_at_symbol.js\u0022:1,\u00220\u0022:1,\u0022sites\\\/all\\\/modules\\\/contrib\\\/google_analytics\\\/googleanalytics.js\u0022:1,\u0022https:\\\/\\\/www.googletagmanager.com\\\/gtag\\\/js?id=G-0K57TCX5BY\u0022:1,\u00221\u0022:1}}});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__dn-cpI1YtkU_iLHgA5WhlkxgYWyat_IxjF_B-WSYrpE__a9hIbt0eaZ7d5nhwnm2weG8R_2eXK4EvoOx9dOxouHE__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__HGACIFBlu2o05y3afvqlt5wrE_5Dn6MXsexfuEpeIwg__t4SOPxucAPoV3Os7g8dXqyMB1HRXQridRJ82X7nE33E__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink rel=\u0027stylesheet\u0027 type=\u0027text\/css\u0027 href=\u0027\/sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css\u0027 \/\u003E\u003C\/head\u003E\u003Cbody\u003E\u003Cdiv class=\u0022panels-ajax-tab-panel panels-ajax-tab-panel-article-tab-full-text\u0022\u003E\u003Cdiv class=\u0022panel-display panel-1col clearfix\u0022 \u003E\n  \u003Cdiv class=\u0022panel-panel panel-col\u0022\u003E\n    \u003Cdiv\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup\u0022 \u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003Cdiv xmlns=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022 data-highwire-cite-ref-tooltip-instance=\u0022highwire_reflinks_tooltip\u0022 class=\u0022content-block-markup\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cdiv class=\u0022article fulltext-view \u0022\u003E\u003Cspan class=\u0022highwire-journal-article-marker-start\u0022\u003E\u003C\/span\u003E\u003Cdiv class=\u0022section abstract\u0022 id=\u0022abstract-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAbstract\u003C\/h2\u003E\u003Cp id=\u0022p-3\u0022\u003E\u003Cstrong\u003EBackground and aims.\u003C\/strong\u003E The first direct-acting antivirals (DAAs) to treat the viral hepatitis C (HCV) became available in 2011. Despite numerous clinical studies of patient outcomes after treatment, few have evaluated changes in the liver microenvironment. Despite achieving sustained virologic response (SVR), patients may still experience adverse outcomes like cirrhosis and hepatocellular carcinoma. By comparing gene and protein expression in liver biopsies collected before and after treatment, we sought to determine whether specific signatures correlated with disease progression and adverse clinical outcomes. \u003Cstrong\u003EMethods.\u003C\/strong\u003E Biopsies were collected from 22 patients before and after DAA treatment. We measured \u223c770 genes and used multispectral imaging with custom machine learning algorithms to analyze phenotypes of intrahepatic macrophages (CD68, CD14, CD16, MAC387, CD163) and T cells (CD3, CD4, CD8, CD45, FoxP3). \u003Cstrong\u003EResults.\u003C\/strong\u003E Before DAA treatment, patients showed two distinct gene expression patterns: one with high pro-inflammatory and antiviral gene expression and another with weaker expression. Patients with adverse outcomes exhibited significantly (p\u0026lt;0.05) more inflammatory activity and had more advanced fibrosis stages in their baseline biopsies than those with liver disease resolution. Patients who achieved SVR had significantly decreased liver enzymes, reduced inflammatory scores, and restored type 1 interferon pathways similar to controls. However, after DAA treatment, patients with persistently high gene expression (67%, pre-hot) still had significantly worse outcomes (p\u0026lt;0.049) despite achieving SVR. A persistent lymphocytic infiltrate was observed in a subset of these patients (76.5%). After therapy, anti-inflammatory macrophages (CD16+, CD16+CD163+, CD16+CD68+) increased, and T cell heterogeneity was more pronounced, showing a predominance of helper and memory T cells (CD3+CD45RO+, CD4+CD45RO+, CD3+CD4+CD45RO+). \u003Cstrong\u003EConclusions.\u003C\/strong\u003E Patients who have more inflamed livers and more advanced fibrosis before DAA treatment should be closely followed for the development of adverse outcomes, even after achieving SVR. We can enhance patient risk stratification by integrating gene and protein expression profiles with clinical data. This could identify those who may benefit from more intensive monitoring or alternative therapeutic approaches, inspiring a new era of personalized patient care.\u003C\/p\u003E\u003Cdiv id=\u0022sec-1\u0022 class=\u0022subsection\u0022\u003E\u003Cp id=\u0022p-4\u0022\u003E\u003Cstrong\u003ELay Summary\u003C\/strong\u003E Direct-acting antiviral (DAA) therapy has dramatically improved the treatment of chronic HCV, making it curable for most people. This study determined gene and protein expression differences in the liver before and after treatment of HCV. These results will lead to a deeper understanding of the changes in the hepatic immune microenvironment with and without the virus present in the liver in hopes of improving patient surveillance, prognosis, and outcome in the future.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-2\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EIntroduction\u003C\/h2\u003E\u003Cp id=\u0022p-17\u0022\u003EAlthough hepatitis C virus (HCV) infection continues to be a global health challenge, with approximately 50 million infected globally and 1 million new cases each year, the landscape has shifted dramatically in recent years due to the availability of direct-acting antiviral (DAA) therapy\u003Csup\u003E\u003Ca id=\u0022xref-ref-1-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-1\u0022\u003E1\u003C\/a\u003E\u003C\/sup\u003E. By selectively targeting enzymes essential for viral replication, DAAs have achieved cure rates higher than 90% \u003Csup\u003E\u003Ca id=\u0022xref-ref-2-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-2\u0022\u003E2\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-3-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-3\u0022\u003E3\u003C\/a\u003E\u003C\/sup\u003E. This has substantially reduced the number of patients progressing to chronic HCV, the occurrence and recurrence of hepatocellular carcinoma (HCC), and all-cause mortality, which represent a significant milestone in the clinical management of patients infected with HCV \u003Csup\u003E\u003Ca id=\u0022xref-ref-4-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-4\u0022\u003E4\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-5-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-5\u0022\u003E5\u003C\/a\u003E\u003C\/sup\u003E. However, despite many patients achieving sustained virologic response (SVR) after DAA treatment, many individuals remain susceptible to reinfection due to the absence of an effective vaccine and the surge in HCV incidence driven by the opioid epidemic. Specifically, injection drug users account for approximately 70% of new HCV infections \u003Csup\u003E\u003Ca id=\u0022xref-ref-6-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-6\u0022\u003E6\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-7-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-7\u0022\u003E7\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-18\u0022\u003EThe liver is a unique immune organ enriched with a diverse array of myeloid and lymphoid cells, and it relies on tolerogenic mechanisms to maintain homeostasis \u003Csup\u003E\u003Ca id=\u0022xref-ref-8-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-8\u0022\u003E8\u003C\/a\u003E\u003C\/sup\u003E. HCV infection disrupts this balance by triggering the activation of both innate (e.g., type I interferons and IFN-stimulated genes) and adaptive immune responses (e.g., helper and cytotoxic T cells), which play a crucial role in either mediating viral clearance or sustaining chronicity \u003Csup\u003E\u003Ca id=\u0022xref-ref-9-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-9\u0022\u003E9\u003C\/a\u003E\u2013\u003Ca id=\u0022xref-ref-12-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-12\u0022\u003E12\u003C\/a\u003E\u003C\/sup\u003E. Inflammatory macrophage activation and cytotoxic T cell responses are typically protective, as they help to control viral replication and eliminate infected cells \u003Csup\u003E\u003Ca id=\u0022xref-ref-13-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-13\u0022\u003E13\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-14-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E\u003C\/sup\u003E. However, the impairment of inflammatory macrophages and T cells, the induction of alternatively activated macrophages involved in tissue repair processes, and the promotion of exhausted T cells, characterized by a loss of effector functions and sustained expression of inhibitory receptors, contribute to HCV persistence in the liver \u003Csup\u003E\u003Ca id=\u0022xref-ref-15-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-15\u0022\u003E15\u003C\/a\u003E\u2013\u003Ca id=\u0022xref-ref-19-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-19\u0022\u003E19\u003C\/a\u003E\u003C\/sup\u003E. Human immunodeficiency virus (HIV) co-infection exacerbates HCV-induced inflammation and impairs both the innate and adaptive immune responses against HCV \u003Csup\u003E\u003Ca id=\u0022xref-ref-20-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-20\u0022\u003E20\u003C\/a\u003E\u003C\/sup\u003E. DAAs have shown the potential to reverse these mechanisms and boost anti-HCV immunity \u003Csup\u003E\u003Ca id=\u0022xref-ref-21-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-21\u0022\u003E21\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-22-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-19\u0022\u003EIn some cases, patients treated with DAAs exhibit persistent inflammation in the portal tracts of the liver, with mild alterations in the fibrosis stage or no improvement \u003Csup\u003E\u003Ca id=\u0022xref-ref-23-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-23\u0022\u003E23\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-24-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-24\u0022\u003E24\u003C\/a\u003E\u003C\/sup\u003E. Post-treatment lymphocytic inflammation is distinguished from other types of active hepatitis by its confinement to the portal tracts without interface and lobular activity, and it can still impose diagnostic challenges for clinicians and pathologists managing HCV cases \u003Csup\u003E\u003Ca id=\u0022xref-ref-25-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E\u003C\/sup\u003E. Persistent lymphocytic portal inflammation is frequently observed in allograft liver biopsies after treatment, which can be puzzling and lead to uncertainty that SVR has been achieved \u003Csup\u003E\u003Ca id=\u0022xref-ref-26-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-26\u0022\u003E26\u003C\/a\u003E\u003C\/sup\u003E. Moreover, it is unclear whether patients who achieve SVR but exhibit histological evidence of persistent lymphocytic inflammation are predisposed to adverse outcomes such as cirrhosis or cancer. Advanced imaging and single-cell platforms have been used to enhance understanding of the changes in the hepatic microenvironment\u2019s cellular composition and spatial distribution \u003Csup\u003E\u003Ca id=\u0022xref-ref-27-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-27\u0022\u003E27\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-28-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-28\u0022\u003E28\u003C\/a\u003E\u003C\/sup\u003E. However, studies of the liver after DAA treatment, in the absence of HCV, are limited. This limitation is partly due to the standard of care for HCV, which no longer includes liver biopsy assessment after treatment, thereby reducing the availability of this tissue for analysis \u003Csup\u003E\u003Ca id=\u0022xref-ref-29-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-29\u0022\u003E29\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-20\u0022\u003EThis study aimed to analyze the gene and protein expression changes in the hepatic microenvironment in patients before and after DAA treatment for HCV. The study\u2019s uniqueness was the availability of liver biopsies in patients after DAA treatment. This allowed us to correlate individual gene and protein signatures detected in the hepatic microenvironment with clinical outcomes and disease progression.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-3\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EMaterials and Methods\u003C\/h2\u003E\u003Cdiv id=\u0022sec-4\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EStudy patients, biopsy collection, and inclusion criteria\u003C\/h3\u003E\u003Cp id=\u0022p-21\u0022\u003EWe evaluated liver biopsies collected from patients before (i.e., pre-treatment) and after (i.e., post-treatment) DAAs from January 2008 to June 2021. The University of Texas Medical Branch (UTMB) Institutional Review Board approved this clinical study (IRB#13-0511). Written informed consent was obtained from all study patients, and the data collected were de-identified. We previously correlated light microscopic histopathologic findings with clinical outcomes in 10 patients \u003Csup\u003E\u003Ca id=\u0022xref-ref-25-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E\u003C\/sup\u003E. Twelve additional patients were added to this cohort (based on tissue availability) to increase the number of patients in each group for molecular and spectral imaging analysis. Sixteen patients had paired pre-and post-treatment biopsies available, while five patients only had pre-treatment biopsies, and one patient had only a post-treatment biopsy collected. We included all ages, women, and minorities in the study. While children were eligible for the study, no participants under 18 met the inclusion criteria at the time of this submission. Demographic data, HCV viral load, and laboratory tests were recorded for each patient included in this study. Liver biopsies were obtained as part of standard care by licensed radiologists and processed in a College of American Pathologists (CAP)-accredited laboratory by licensed histotechnologists as described previously \u003Csup\u003E\u003Ca id=\u0022xref-ref-25-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E\u003C\/sup\u003E. The biopsies were evaluated using established numerical scoring systems for histologic features of hepatitis inflammatory activity, fibrosis staging, and steatosis grading \u003Csup\u003E\u003Ca id=\u0022xref-ref-30-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-30\u0022\u003E30\u003C\/a\u003E\u2013\u003Ca id=\u0022xref-ref-32-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-32\u0022\u003E32\u003C\/a\u003E\u003C\/sup\u003E. The assessments were conducted by a board-certified liver pathologist (H.S.L) blinded to the patient\u2019s serology, clinical history, and prior pathology reports. The modified hepatitis activity index (MHAI) assesses parameters to evaluate hepatic inflammatory activity, including periportal\/periseptal interface hepatitis, confluent necrosis, focal lytic necrosis\/apoptosis, and the amount of portal inflammation \u003Csup\u003E\u003Ca id=\u0022xref-ref-30-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-30\u0022\u003E30\u003C\/a\u003E\u003C\/sup\u003E. The Ishak criteria were used for staging fibrosis \u003Csup\u003E\u003Ca id=\u0022xref-ref-30-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-30\u0022\u003E30\u003C\/a\u003E\u003C\/sup\u003E. Liver biopsy images for each patient were acquired using an Aperio Image Scope Digital slide scanner (Leica Biosystems, Buffalo Grove, IL). Tissue blocks were stored at room temperature and sectioned just before staining whenever possible. Slides that could not be stained within one week were wrapped in parafilm and stored at \u221280\u00b0C with desiccant to minimize moisture exposure.\u003C\/p\u003E\u003Cp id=\u0022p-22\u0022\u003ELiver biopsies used as controls were from patients that met the following criteria: no history of previous HCV infection or any other hepatotropic viral infection, no history of HIV, no history of congenital or acquired liver disease, no history of excessive alcohol or substance abuse, no history of metastatic liver cancer, and no history of immune-mediated liver disease. Their liver biopsies also had to have no histopathologic findings with liver enzymes (alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) in the normal range at the time of the biopsy.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-5\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EDAA treatment regimens and response to therapy\u003C\/h3\u003E\u003Cp id=\u0022p-23\u0022\u003EDifferent DAA combinations were administered for up to 12 weeks to treat the patients according to international guidelines. Patients were retrospectively followed after DAA treatment, and only those who achieved SVR were included. None of the patients had serologic evidence of coinfection with other hepatotropic viruses (e.g., hepatitis A, B, or E) or immune-mediated liver disease at the time of diagnosis or during the study.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-6\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ELaboratory tests\u003C\/h3\u003E\u003Cp id=\u0022p-24\u0022\u003EWe compared laboratory studies ((ALT, AST, ALP), albumin, bilirubin, platelets, prothrombin time (PT), and international normalized ratio (INR)) in the patients pre- and post-DAA treatment (nL=L22). Viral load, genotype, and liver enzymes were measured in blood samples using standard molecular procedures in an in-house CAP and clinical laboratory improvement amendments (CLIA)-accredited clinical chemistry laboratory, as previously described \u003Csup\u003E\u003Ca id=\u0022xref-ref-25-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E\u003C\/sup\u003E. Laboratory data were collected for each patient during the baseline liver biopsy, between three- and four months post-DAA treatment, to determine the presence of SVR and at follow-up.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-7\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ERNA isolation and quality assurance for downstream applications\u003C\/h3\u003E\u003Cp id=\u0022p-25\u0022\u003ERNA was extracted from FFPE unstained sections and fresh liver biopsies and assessed for quality. Samples meeting strict quality criteria (DV300 \u0026gt; 50%, 260\/280 ratio \u2265 1.7) were analyzed using NanoString\u2019s PanCancer Immune Panel (NanoString, Bruker Spatial Biology, Seattle, WA, USA).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-8\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EnCounter gene expression analysis\u003C\/h3\u003E\u003Cp id=\u0022p-26\u0022\u003EThe nCounter platform (NanoString, Bruker Spatial Biology, Seattle, WA, USA) is optimized for use FFPE and fresh tissue samples. Studies conducted on specimens of varying ages have shown no significant differences in performance, indicating the platform\u2019s robustness across various sample types and ages \u003Csup\u003E\u003Ca id=\u0022xref-ref-33-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-33\u0022\u003E33\u003C\/a\u003E\u003C\/sup\u003E. To determine gene expression profiling, 50 to 150 ng of the isolated RNA were hybridized with the PanCancer Immune Panel, which includes 730 immuno-oncology-related targets and \u223c40 housekeeping genes. This panel was chosen since it contains most of the immunological, inflammatory, and anti-viral pathways activated during an HCV infection. The raw data (RCC files) were imported into nSolver\u2122 analysis software v4.0 (NanoString, Bruker Spatial Biology, Seattle, WA, USA). Preliminary analysis evaluated quality control parameters, including imagen QC, binding density, detection limit, and positive controls. Samples with values outside normal ranges (flagged) were assessed to determine if they needed to be excluded. Housekeeping selection, normalization, differential expression, and immune-related scores calculation were performed in the advanced analysis module within the nSolver\u2122 Analysis Software.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-9\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EDifferential gene expression\u003C\/h3\u003E\u003Cp id=\u0022p-27\u0022\u003ENormalized data from the nSolver\u2122 software was used to establish gene expression signatures. To explore the gene expression patterns among HCV pre- and post-DAA therapy groups and liver controls, a hierarchical clustering analysis based on Z-score transformed data was performed using the R statistical environment (version 3.3.2). The results of these analyses were visually represented through heat maps, accompanied by a dendrogram tree. Next, we conducted a principal component analysis (PCA) on the covariance matrix using the regularized log2-transformed gene data in GraphPad Prism v.10 (GraphPad Software, San Diego, CA, USA). A Venn diagram was also constructed using the significant differentially expressed genes (DEGs) between the individual HCV groups and the liver controls. The selection of significant DEGs was based on an adjusted Benjamini-Yekutieli (BY) p-value cut-off \u0026lt;0.01 and a log2 fold change \u2264-0.6 or \u22650.6.\u003C\/p\u003E\u003Cp id=\u0022p-28\u0022\u003EThe volcano plots in DEGs were used to illustrate gene profiling among HCV pre- and post-DAA therapy groups compared to liver controls and between subclusters. Volcano plots were generated using the nSolver software and visualized using GraphPad Prism v.10 (GraphPad Software, San Diego, CA, USA). Each gene\u2019s \u2212log10(p-value) was plotted on the x-axis, while the log2 fold change was represented on the y-axis. Genes positioned above the predefined threshold adjusted Benjamini-Yekutieli (BY) p-value cut-off \u0026lt;0.05 and log2 fold change \u2264-0.6 or \u22650.6) were identified as differentially expressed. The Database for Annotation, Visualization, and Integrated Discovery (DAVID) is a powerful bioinformatics tool and web-based platform that offers a suite of enrichment analysis tools, enabling explore the functional implications of DEGs within the context of biological pathways \u003Csup\u003E\u003Ca id=\u0022xref-ref-34-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-34\u0022\u003E34\u003C\/a\u003E\u003C\/sup\u003E. The DAVID tool, integrated with the Reactome database, was used to identify enriched pathways in DEGs among the HCV pre- and post-DAA therapy groups compared to liver controls.\u003C\/p\u003E\u003Cp id=\u0022p-29\u0022\u003EWe conducted a cell deconvolution analysis utilizing the online tool CIBERSORT (Cell Type Identification by Estimating Relative Samples of RNA Transcripts) to assess the proportions of immune cell subtypes in different HCV groups and controls. The CIBERSORT tool was employed with default parameters, using the LM22 expression profile matrix encompassing 22 types of immune cells \u003Csup\u003E\u003Ca id=\u0022xref-ref-35-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-35\u0022\u003E35\u003C\/a\u003E\u003C\/sup\u003E. We examined each sample\u2019s normalized gene expression levels (log2) of lineage markers and calculated the p-values using 100 permutations.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-10\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EMultispectral imaging analysis\u003C\/h3\u003E\u003Cp id=\u0022p-30\u0022\u003EUsing two additional unstained slides from each tissue FFPE tissue block, we stained with two separate multiplex antibody panels, one for macrophages (CD68, CD163, Mac387, CD14, and CD16) and DAPI and another for T cells (CD3, CD4, CD8, CD45RO, and FoxP3) and DAPI. Staining was conducted manually or with the Ventana Discovery Ultra (Roche Diagnostics, Indianapolis, IN) as previously described \u003Csup\u003E\u003Ca id=\u0022xref-ref-36-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-36\u0022\u003E36\u003C\/a\u003E\u003C\/sup\u003E and they were using the conditions as detailed in \u003Cstrong\u003E\u003Ca id=\u0022xref-table-wrap-1-1\u0022 class=\u0022xref-table\u0022 href=\u0022#T1\u0022\u003ETable S1\u003C\/a\u003E-2\u003C\/strong\u003E. Images were acquired using the Vectra 3 Quantitative Pathology Imaging system (Akoya Biosciences, Marlborough, MA). Regions of interest (ROIs) were obtained from at least 50% of the surface area of each liver biopsy from each patient. Stamped areas for acquisition were 2 x 2 (1338 \u00b5m x 1000 \u00b5m) at a resolution of 0.5 \u00b5m (20X). Acquired images from the macrophage panel staining were analyzed using phenotyping algorithms (inForm, Akoya Biosciences) and merged cell seq_files. Multi-component TIFF images from the macrophage and T cell panels were imported into Visiopharm software (Visiopharm, Hoersholm, Denmark). The images were stitched and analyzed using custom artificial intelligence (AI) applications and deep learning algorithms designed for tissue detection, nuclear detection, and cell phenotyping. Phenotypes were calculated as the number of cells per analyzed area across all ROIs collected from each patient. The phenotyping workflow tool was used to guide and annotate each of the patient\u2019s whole-slide images before batch analysis. These customizations added another layer of scrutiny, optimizing the algorithm to identify each phenotype according to the variability of each patient\u2019s collected images.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-11\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EStatistical analyses\u003C\/h3\u003E\u003Cp id=\u0022p-31\u0022\u003EData analysis and boxplot figures were performed using GraphPad Prism v10 (GraphPad Software, San Diego, CA, USA). Descriptive statistics were calculated to summarize the mean, median, and standard deviation (SD). Normal distribution was determined using the D\u2019Agostino-Pearson test or the Shapiro-Wilk test. An unpaired t-test (parametric) or Mann-Whitney test (nonparametric), as appropriate, was used to compare the differences between the two groups. A one-way ANOVA with multiple comparisons, Tukey\u2019s post-hoc test (parametric) or Dunn\u2019s (nonparametric), was used to compare the differences between three or more groups. A p-value \u0026lt;0.05 was considered statistical significance. The Fisher test determined the association between gene expression pre-DAA treatment and outcomes. OR ratios \u0026gt;1 are regarded as a positive association. R2 values\u0026gt;0 suggest a positive correlation.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-12\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EResults\u003C\/h2\u003E\u003Cdiv id=\u0022sec-13\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EDemographics, study design, histological scoring, and clinical data\u003C\/h3\u003E\u003Cp id=\u0022p-32\u0022\u003EThe main goal of this study was to analyze changes in gene and protein expression in the hepatic microenvironment before and after DAA treatment to determine how the immune landscape responds when the virus has been cleared. We also correlated gene and protein signatures with inflammatory activity, fibrosis stages, and clinical outcomes. We previously correlated the light microscopy findings with clinical outcomes in 10 patients \u003Csup\u003E\u003Ca id=\u0022xref-ref-25-5\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E\u003C\/sup\u003E. In this study, we increased the number of patients to 22 and further evaluated gene and protein expression using nCounter and multispectral imaging. Patient demographics, histological scoring, and clinical data, including viral loads and genotypes, are shown in \u003Cstrong\u003ETable 1\u003C\/strong\u003E. The study group consisted of male (14\/22) and female (8\/22) patients with a mean age of 52 \u00b1L6.04 SD years when the first biopsy was collected and a mean age of 55 \u00b1L7.3 SD years when the post-treatment biopsy was collected. Fifty percent of the patients were non-Hispanic whites (11\/22), 27.3% were Hispanic whites (6\/22), and 27.3% were African American (6\/22) (data not shown). Patients had a mean body mass index (BMI) of 28.22 \u00b1L6.09 SD kg\/m2 and 29.7 \u00b1L6.97 SD kg\/m2 at the time of the first and second biopsies, respectively (p = 0.52). The HCV viral load ranged from 1.15L\u00d7L10\u003Csup\u003E4\u003C\/sup\u003E to 1.72L\u00d7L10\u003Csup\u003E7\u003C\/sup\u003E IU\/mL before DAA treatment. All patients achieved SVR (i.e., undetectable viral RNA for 12 weeks or more post-treatment) independent of the DAA regimen. The most prevalent genotype was 1a (12\/22), followed by 1b (4\/22) and 2b (4\/22). The experimental workflow is shown in \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-1-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFig. 1A\u003C\/a\u003E\u003C\/strong\u003E. Liver biopsies were collected from the study patients pre and post-DAA treatment. RNA from Study Patient Set 1 (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-1-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFig. 1A\u003C\/a\u003E\u003C\/strong\u003E) was subject to NanoString nCounter gene expression analysis. Unstained liver biopsy sections from Study Patient Set 2 were stained with the macrophage phenotyping panel (CD68, CD14, CD16, CD163, MAC387, and DAPI). In contrast, unstained slides from Study Patient Set 3 were stained with the T cell phenotype panel (CD3, CD4, CD8, FoxP3, CD45RO, and DAPI) and analyzed by multispectral imaging. After treatment, patients had significantly decreased (p\u0026lt;0.001) inflammatory activity in their liver (mean and SD of 4.81 MHAI \u00b1L 2.10 and 2.4 MHAI \u00b1L1.14 at the time of the first and second biopsies), and significantly decreased (p\u0026lt;0.01) transaminase levels (mean and SD of AST before 67 U\/L \u00b1 74, and after treatment 28 U\/L \u00b1 11.56; mean and SD of ALT before 74 U\/L \u00b1 79.64 and after treatment 28.4 U\/L \u00b1 11.6). There were no significant differences in the fibrosis stage or ALP levels after treatment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-1-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFig. 1B\u003C\/a\u003E\u003C\/strong\u003E).\u003C\/p\u003E\u003Cdiv id=\u0022F1\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F1.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Experimental workflow and comparison of clinical data of patients pre- and post-DAA treatment for viral hepatitis C. (A) This study evaluated differences in the hepatic microenvironment of liver biopsies collected from patients with HCV (n = 22), including pre-DAA (n = 21) and post-DAA treatment (n = 17), and controls (n = 15) using gene expression and spectral imaging analysis (see also Table 1). The tables with the Study Patient Sets show the number of patients included in each experiment. In the post-treatment group, the biopsy was obtained after achieving SVR. Next, RNA was extracted from fresh liver and FFPE unstained slides for nCounter analysis (Study Patient Set 1). Then, spectral imaging was performed by staining pre- and post-treatment liver biopsies of each patient with a macrophage (Study Patient Set 2) and T cell (Study Patient Set 3) panels and scanned with the Vectra 3 automated quantitative pathology imaging system. Multicomponent TIFFs were imported into the Visiopharm digital software platform to generate phenotype profile maps. (B) After DAA treatment, patients had significantly decreased inflammatory activity by liver biopsy evaluation and decreased hepatic transaminase levels (ALT and AST) when compared to pre-treatment. Liver biopsies were graded for inflammatory activity using the MHAI scoring criteria (0-18) and staged for fibrosis using Ishak (1-6) criteria. Normal distribution was tested, and an unpaired t-test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001. Abbreviations: Pre, (Pre-DAA treatment); Post, (Post-DAA treatment); MHAI, modified hepatic activity index; ALT, Alanine transaminase; AST, Aspartate aminotransferase; ALP, Alkaline phosphatase; FFPE, Formalin-fixed paraffin-embedded; PT, Prothrombin time; INR, International Normalized Ratio.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1289227155\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Experimental workflow and comparison of clinical data of patients pre- and post-DAA treatment for viral hepatitis\u0026lt;\/span\u0026gt; \u0026lt;strong\u0026gt;C.\u0026lt;\/strong\u0026gt; (\u0026lt;strong\u0026gt;A\u0026lt;\/strong\u0026gt;) This study evaluated differences in the hepatic microenvironment of liver biopsies collected from patients with HCV (n = 22), including pre-DAA (n = 21) and post-DAA treatment (n = 17), and controls (n = 15) using gene expression and spectral imaging analysis (see also \u0026lt;strong\u0026gt;Table 1\u0026lt;\/strong\u0026gt;). The tables with the Study Patient Sets show the number of patients included in each experiment. In the post-treatment group, the biopsy was obtained after achieving SVR. Next, RNA was extracted from fresh liver and FFPE unstained slides for nCounter analysis (\u0026lt;strong\u0026gt;Study Patient Set 1\u0026lt;\/strong\u0026gt;). Then, spectral imaging was performed by staining pre- and post-treatment liver biopsies of each patient with a macrophage (\u0026lt;strong\u0026gt;Study Patient Set 2\u0026lt;\/strong\u0026gt;) and T cell (\u0026lt;strong\u0026gt;Study Patient Set 3\u0026lt;\/strong\u0026gt;) panels and scanned with the Vectra 3 automated quantitative pathology imaging system. Multicomponent TIFFs were imported into the Visiopharm digital software platform to generate phenotype profile maps. (\u0026lt;strong\u0026gt;B\u0026lt;\/strong\u0026gt;) After DAA treatment, patients had significantly decreased inflammatory activity by liver biopsy evaluation and decreased hepatic transaminase levels (ALT and AST) when compared to pre-treatment. Liver biopsies were graded for inflammatory activity using the MHAI scoring criteria (0-18) and staged for fibrosis using Ishak (1-6) criteria. Normal distribution was tested, and an unpaired t-test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001. Abbreviations: Pre, (Pre-DAA treatment); Post, (Post-DAA treatment); MHAI, modified hepatic activity index; ALT, Alanine transaminase; AST, Aspartate aminotransferase; ALP, Alkaline phosphatase; FFPE, Formalin-fixed paraffin-embedded; PT, Prothrombin time; INR, International Normalized Ratio.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 1.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F1.medium.gif\u0022 width=\u0022376\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 1.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F1.medium.gif\u0022 width=\u0022376\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F1.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 1.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F1.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 1.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EExperimental workflow and comparison of clinical data of patients pre- and post-DAA treatment for viral hepatitis\u003C\/span\u003E\u003Cp id=\u0022p-33\u0022 class=\u0022first-child\u0022\u003E\u003Cstrong\u003EC.\u003C\/strong\u003E (\u003Cstrong\u003EA\u003C\/strong\u003E) This study evaluated differences in the hepatic microenvironment of liver biopsies collected from patients with HCV (n = 22), including pre-DAA (n = 21) and post-DAA treatment (n = 17), and controls (n = 15) using gene expression and spectral imaging analysis (see also \u003Cstrong\u003ETable 1\u003C\/strong\u003E). The tables with the Study Patient Sets show the number of patients included in each experiment. In the post-treatment group, the biopsy was obtained after achieving SVR. Next, RNA was extracted from fresh liver and FFPE unstained slides for nCounter analysis (\u003Cstrong\u003EStudy Patient Set 1\u003C\/strong\u003E). Then, spectral imaging was performed by staining pre- and post-treatment liver biopsies of each patient with a macrophage (\u003Cstrong\u003EStudy Patient Set 2\u003C\/strong\u003E) and T cell (\u003Cstrong\u003EStudy Patient Set 3\u003C\/strong\u003E) panels and scanned with the Vectra 3 automated quantitative pathology imaging system. Multicomponent TIFFs were imported into the Visiopharm digital software platform to generate phenotype profile maps. (\u003Cstrong\u003EB\u003C\/strong\u003E) After DAA treatment, patients had significantly decreased inflammatory activity by liver biopsy evaluation and decreased hepatic transaminase levels (ALT and AST) when compared to pre-treatment. Liver biopsies were graded for inflammatory activity using the MHAI scoring criteria (0-18) and staged for fibrosis using Ishak (1-6) criteria. Normal distribution was tested, and an unpaired t-test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001. Abbreviations: Pre, (Pre-DAA treatment); Post, (Post-DAA treatment); MHAI, modified hepatic activity index; ALT, Alanine transaminase; AST, Aspartate aminotransferase; ALP, Alkaline phosphatase; FFPE, Formalin-fixed paraffin-embedded; PT, Prothrombin time; INR, International Normalized Ratio.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-14\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EDAA treatment attenuates pro-inflammatory and antiviral pathways in patients with HCV after they achieve SVR\u003C\/h3\u003E\u003Cp id=\u0022p-34\u0022\u003EGiven that RNA was extracted from FFPE and fresh tissue, we included another step to compare and analyze housekeeping gene expression, excluding samples flagged by the nCounter platform (data not shown). Gene expression patterns formed two main clusters in the heatmap (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2A\u003C\/a\u003E\u003C\/strong\u003E). One cluster (right) was characterized by overall low gene expression and consisted of controls (A-I, orange labels), most patients post-DAA treatment (brown labels; pt 1, 5, 7-11, 13, 19-21), and some patients pre-treatment (turquoise labels; pt 5-8, 15-18). The second cluster (left) displayed high gene expression levels across the 730 genes analyzed and consisted of most patients pre-DAA treatment (pt 10-14 and 19-22) and three patients post-DAA treatment (pt 6,12, 22). PCA analysis showed a similar clustering pattern (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2B\u003C\/a\u003E\u003C\/strong\u003E). We then used volcano plots to compare the genes responsible for the heatmap clustering. In agreement with other studies, genes known to be associated with inflammatory (e.g., STAT1, STAT2, CXCL10, CXCL9, IFNAR2) and interferon-induced-antiviral (i.e., ISG15, OAS3, MX1, IFI27, and IFI35) responses were upregulated before DAA treatment when compared to the control (Top) and post-treatment groups (Bottom) (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2C\u003C\/a\u003E, Table S3-4)\u003C\/strong\u003E \u003Csup\u003E\u003Ca id=\u0022xref-ref-37-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-37\u0022\u003E37\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-38-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-38\u0022\u003E38\u003C\/a\u003E\u003C\/sup\u003E. Notably, a significant downregulation of the same genes was observed post-DAA treatment. In most patients who achieved SVR, no significant differences were observed between post-DAA patients and controls (data not shown). Using the most critical genes (as determined by differential gene expression analysis) to compare patients before treatment to controls, we determined that the top enriched pathways were involved in essential biological processes (including genes associated with immunity, innate immunity, and host-virus interactions) and were composed of specific cell components (including membrane, cytoplasm, and secretion systems) (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2D\u003C\/a\u003E\u003C\/strong\u003E). Similar to other studies, we observed a significant (p\u0026lt;0.01) downregulation of inflammatory (e.g., CXCL10, STAT1) and interferon-induced antiviral genes (e.g., Mx1, OAS3, ISG15\/20, IFI27\/35, IFIT1) post-DAA treatment \u003Csup\u003E\u003Ca id=\u0022xref-ref-39-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-39\u0022\u003E39\u003C\/a\u003E\u003C\/sup\u003E. In addition, we observed heterogeneity in individual patients pre- and post-DAA treatment, as shown by the marked differences in Log2 levels in each group (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2E\u003C\/a\u003E\u003C\/strong\u003E).\u003C\/p\u003E\u003Cdiv id=\u0022F2\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F2.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022nCounter analysis showed decreased expression of antiviral and pro-inflammatory genes in patients after DAA therapy (A) Cluster analysis using nSolver software categorized gene expression profiling data from liver biopsies of controls (n = 9), patients with HCV pre-(n = 17), and post-DAA treatment (n = 14). The resulting heatmap revealed two main clusters: one was primarily composed of patients before treatment (with increased upregulated genes, red), and the other cluster included mostly patients after treatment, including controls (with more downregulated genes, blue). (B) Principal component analysis (PCA) obtained from Log2-transformed data confirmed the clustering observed in the heatmap. (C) Volcano plots comparing the gene expression from the liver biopsies of patients pre- and post-DAA treatment vs controls and pre-vs post-DAA treatment show that genes associated with antiviral and pro-inflammatory response were upregulated pre-DAA treatment and returned to baseline post-treatment. Solid and dashed lines indicate the \u0026#x2013;log10 adjustable (BY) p-value \u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1289227155\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;nCounter analysis showed decreased expression of antiviral and pro-inflammatory genes in patients after DAA therapy\u0026lt;\/span\u0026gt; (\u0026lt;strong\u0026gt;A\u0026lt;\/strong\u0026gt;) Cluster analysis using nSolver software categorized gene expression profiling data from liver biopsies of controls (n = 9), patients with HCV pre-(n = 17), and post-DAA treatment (n = 14). The resulting heatmap revealed two main clusters: one was primarily composed of patients before treatment (with increased upregulated genes, red), and the other cluster included mostly patients after treatment, including controls (with more downregulated genes, blue). (\u0026lt;strong\u0026gt;B\u0026lt;\/strong\u0026gt;) Principal component analysis (PCA) obtained from Log2-transformed data confirmed the clustering observed in the heatmap. (\u0026lt;strong\u0026gt;C\u0026lt;\/strong\u0026gt;) Volcano plots comparing the gene expression from the liver biopsies of patients pre- and post-DAA treatment vs controls and pre-vs post-DAA treatment show that genes associated with antiviral and pro-inflammatory response were upregulated pre-DAA treatment and returned to baseline post-treatment. Solid and dashed lines indicate the \u0026#x2013;log10 adjustable (BY) p-value \u0026lt;0.01 or \u0026lt;0.05, respectively. Vertical dashed lines represent the log2 fold change \u0026lt;-0.6 or \u0026gt;0.6. (\u0026lt;strong\u0026gt;D\u0026lt;\/strong\u0026gt;) Differential gene expression obtained from comparing pre-DAA versus control groups was used to determine enriched pathways using DAVID software and the Reactome database. The y-axis represents the top enriched pathways. The color of the dots represents the \u0026#x2212;Log10 of the adjusted p-value obtained from the enrichment analysis. \u0026#x2013;Log10 \u0026gt; 2 (adjusted p-value= \u0026#x2264;0.01) indicates significant enrichment (yellow dots represent higher significance). (\u0026lt;strong\u0026gt;E\u0026lt;\/strong\u0026gt;) Scatter box plots show significant downregulation of specific antiviral and type I interferon-induced genes in patients post-DAA treatment, like levels observed in the control group. Normal distribution was tested, and One-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001; ****p \u0026lt; 0.0001. Abbreviations: Ctrl (Controls), Pre-(Pre-DAA treatment), Post (Post-DAA treatment).\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 2.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F2.medium.gif\u0022 width=\u0022337\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 2.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F2.medium.gif\u0022 width=\u0022337\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F2.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 2.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F2.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 2.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EnCounter analysis showed decreased expression of antiviral and pro-inflammatory genes in patients after DAA therapy\u003C\/span\u003E\u003Cp id=\u0022p-35\u0022 class=\u0022first-child\u0022\u003E(\u003Cstrong\u003EA\u003C\/strong\u003E) Cluster analysis using nSolver software categorized gene expression profiling data from liver biopsies of controls (n = 9), patients with HCV pre-(n = 17), and post-DAA treatment (n = 14). The resulting heatmap revealed two main clusters: one was primarily composed of patients before treatment (with increased upregulated genes, red), and the other cluster included mostly patients after treatment, including controls (with more downregulated genes, blue). (\u003Cstrong\u003EB\u003C\/strong\u003E) Principal component analysis (PCA) obtained from Log2-transformed data confirmed the clustering observed in the heatmap. (\u003Cstrong\u003EC\u003C\/strong\u003E) Volcano plots comparing the gene expression from the liver biopsies of patients pre- and post-DAA treatment vs controls and pre-vs post-DAA treatment show that genes associated with antiviral and pro-inflammatory response were upregulated pre-DAA treatment and returned to baseline post-treatment. Solid and dashed lines indicate the \u2013log10 adjustable (BY) p-value \u0026lt;0.01 or \u0026lt;0.05, respectively. Vertical dashed lines represent the log2 fold change \u0026lt;-0.6 or \u0026gt;0.6. (\u003Cstrong\u003ED\u003C\/strong\u003E) Differential gene expression obtained from comparing pre-DAA versus control groups was used to determine enriched pathways using DAVID software and the Reactome database. The y-axis represents the top enriched pathways. The color of the dots represents the \u2212Log10 of the adjusted p-value obtained from the enrichment analysis. \u2013Log10 \u0026gt; 2 (adjusted p-value= \u22640.01) indicates significant enrichment (yellow dots represent higher significance). (\u003Cstrong\u003EE\u003C\/strong\u003E) Scatter box plots show significant downregulation of specific antiviral and type I interferon-induced genes in patients post-DAA treatment, like levels observed in the control group. Normal distribution was tested, and One-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001; ****p \u0026lt; 0.0001. Abbreviations: Ctrl (Controls), Pre-(Pre-DAA treatment), Post (Post-DAA treatment).\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-36\u0022\u003EThe relative proportion of immune cells contributing to the liver landscape in the patient groups was estimated using CIBERSORT, which uses a reference dataset of gene expression signatures from known cell types \u003Csup\u003E\u003Ca id=\u0022xref-ref-35-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-35\u0022\u003E35\u003C\/a\u003E\u003C\/sup\u003E. While the proportion of monocytes decreased in both the pre- and post-DAA groups, the proportion of pro-inflammatory (M1) macrophages was significantly (p\u0026lt;0.05) increased pre-treatment compared to uninfected controls and decreased (p\u0026lt;0.01) after treatment. T regulatory cells (T regs) were increased before treatment and did not return to baseline after treatment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3A, B\u003C\/a\u003E\u003C\/strong\u003E). Specific macrophage and T cell genes accounting for cell deconvolution are shown in \u003Cstrong\u003EFig. S1A\u003C\/strong\u003E. Unexpectedly, gene expression of molecules associated with both inflammatory and anti-inflammatory responses, CD14 and CD16, was significantly elevated in the control group compared to both the pre- and post-treatment groups. At the same time, no significant difference was observed between the pre- and post-treatment groups (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3C\u003C\/a\u003E\u003C\/strong\u003E). As for molecules associated with specific T cell phenotypes, CD4 and CD8, results were mixed, and the control group exhibited significantly higher expression of CD4 compared to the pre- and post-treatment groups. In contrast, CD8 expression was significantly elevated in both the pre- and post-treatment groups compared to controls (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3D\u003C\/a\u003E\u003C\/strong\u003E). This dichotomy led us to investigate the protein expression of these markers further, as will be discussed later (see multispectral imaging section).\u003C\/p\u003E\u003Cdiv id=\u0022F3\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F3.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Cell deconvolution analysis showed that pro-inflammatory (M1) macrophages returned to baseline after DAA treatment, while gene expression for regulatory T cells (T regs) remained elevated (A) Gene expression was analyzed using CIBERSORT 35. We applied this tool, which uses a reference dataset of gene expression signatures from known cell types, to estimate the relative proportions of different immune cell types in liver biopsies from controls (n = 9) compared with those from patients pre-(n = 17) and post-DAA treatment (n = 14). (B) CIBERSORT showed individual variation in specific macrophage and T cell populations among the study groups. After DAA treatment, liver biopsies showed a significantly decreased prevalence of pro-inflammatory (M1) macrophages (light purple), like controls. T reg genes (bright green) significantly increased with HCV infection and were at similar levels after treatment. Specific M1 and T reg genes enriched in the patient\u0026#x2019;s pre-DAA treatment are shown in Figure S1A. (C-D) Box plots compare Log2 gene expression of resident, pro-inflammatory and anti-inflammatory macrophages, and T cell markers among the groups. Normal distribution was tested, and a One-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001. Abbreviations: Ctrl (Controls), Pre-(Pre-DAA therapy), Post (Post-DAA therapy).\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1289227155\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Cell deconvolution analysis showed that pro-inflammatory (M1) macrophages returned to baseline after DAA treatment, while gene expression for regulatory T cells (T regs) remained elevated\u0026lt;\/span\u0026gt; (\u0026lt;strong\u0026gt;A\u0026lt;\/strong\u0026gt;) Gene expression was analyzed using CIBERSORT \u0026lt;sup\u0026gt;35\u0026lt;\/sup\u0026gt;. We applied this tool, which uses a reference dataset of gene expression signatures from known cell types, to estimate the relative proportions of different immune cell types in liver biopsies from controls (n = 9) compared with those from patients pre-(n = 17) and post-DAA treatment (n = 14). (\u0026lt;strong\u0026gt;B\u0026lt;\/strong\u0026gt;) CIBERSORT showed individual variation in specific macrophage and T cell populations among the study groups. After DAA treatment, liver biopsies showed a significantly decreased prevalence of pro-inflammatory (M1) macrophages (light purple), like controls. T reg genes (bright green) significantly increased with HCV infection and were at similar levels after treatment. Specific M1 and T reg genes enriched in the patient\u0026#x2019;s pre-DAA treatment are shown in \u0026lt;strong\u0026gt;Figure S1A.\u0026lt;\/strong\u0026gt; (\u0026lt;strong\u0026gt;C-D\u0026lt;\/strong\u0026gt;) Box plots compare Log2 gene expression of resident, pro-inflammatory and anti-inflammatory macrophages, and T cell markers among the groups. Normal distribution was tested, and a One-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001. Abbreviations: Ctrl (Controls), Pre-(Pre-DAA therapy), Post (Post-DAA therapy).\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 3.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F3.medium.gif\u0022 width=\u0022411\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 3.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F3.medium.gif\u0022 width=\u0022411\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F3.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 3.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F3.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 3.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003ECell deconvolution analysis showed that pro-inflammatory (M1) macrophages returned to baseline after DAA treatment, while gene expression for regulatory T cells (T regs) remained elevated\u003C\/span\u003E\u003Cp id=\u0022p-37\u0022 class=\u0022first-child\u0022\u003E(\u003Cstrong\u003EA\u003C\/strong\u003E) Gene expression was analyzed using CIBERSORT \u003Csup\u003E\u003Ca id=\u0022xref-ref-35-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-35\u0022\u003E35\u003C\/a\u003E\u003C\/sup\u003E. We applied this tool, which uses a reference dataset of gene expression signatures from known cell types, to estimate the relative proportions of different immune cell types in liver biopsies from controls (n = 9) compared with those from patients pre-(n = 17) and post-DAA treatment (n = 14). (\u003Cstrong\u003EB\u003C\/strong\u003E) CIBERSORT showed individual variation in specific macrophage and T cell populations among the study groups. After DAA treatment, liver biopsies showed a significantly decreased prevalence of pro-inflammatory (M1) macrophages (light purple), like controls. T reg genes (bright green) significantly increased with HCV infection and were at similar levels after treatment. Specific M1 and T reg genes enriched in the patient\u2019s pre-DAA treatment are shown in \u003Cstrong\u003EFigure S1A.\u003C\/strong\u003E (\u003Cstrong\u003EC-D\u003C\/strong\u003E) Box plots compare Log2 gene expression of resident, pro-inflammatory and anti-inflammatory macrophages, and T cell markers among the groups. Normal distribution was tested, and a One-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001. Abbreviations: Ctrl (Controls), Pre-(Pre-DAA therapy), Post (Post-DAA therapy).\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-15\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EA comparison of different clusters identified in the gene expression heat map revealed distinct groups of patients in the pre- and post-DAA groups\u003C\/h3\u003E\u003Cp id=\u0022p-38\u0022\u003EWe further explored the two clusters identified during the gene expression analysis (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2A\u003C\/a\u003E\u003C\/strong\u003E). Within the pre- and post-DAA groups, two distinct gene expression and clustering patterns were present (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig 4 A-C\u003C\/a\u003E\u003C\/strong\u003E). We examined the differences between patients pre-DAA with high gene expression (pre-hot; pt 10-14 and 19-22; n = 9) and low gene expression (pre-cold; pt 5-8 and 15-18; n = 8) and compared each of these groups to controls. Like the pre-DAA group, the pre-hot subcluster had increased inflammatory activity (by MHAI scores) and ALT values (\u003Cstrong\u003EFig. S2\u003C\/strong\u003E), which decreased after treatment (p\u0026lt;0.05). Moreover, pre-hot patients had significantly (p\u0026lt;0.01) increased MHAI scores compared to the pre-cold patients (\u003Cstrong\u003EFig. S2\u003C\/strong\u003E). When compared to controls, patients in the pre-hot group exhibited significantly more upregulated genes with higher fold changes in expression compared to the pre-cold group, as illustrated in the volcano plots and Venn diagram (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4A\u003C\/a\u003E, Fig. S3 - S4, Table S5-S7\u003C\/strong\u003E). Some genes associated with the JAK\/STAT pathway (JAK2, STAT1), TNF (TNFSF4, CYLD), and interleukins (IL-32, IL-17RB) were exclusively expressed in the pre-hot group (\u003Cstrong\u003EFig. S4D)\u003C\/strong\u003E. However, we found that both groups of HCV-infected patients (pre-hot and pre-cold) showed significant gene expression differences (up\/downregulated: pre-hot, 162 genes; pre-cold, seven genes; and seven overlapping genes) compared to controls (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4C\u003C\/a\u003E; Fig. S3A, C; Tables S6-7\u003C\/strong\u003E). Interestingly, differentially expressed genes in the pre-hot patients were not the conventional type I\/III IFN-induced genes or antiviral genes, but instead, genes associated with liver cancer progression (i.e., CXCR4, BCL2, FYN) and genes with the potential to exacerbate the inflammatory response (i.e., NLRC5, LTB, CCL3, IKBKE, IRF7, JAK3, TNFAIP3, CXCL9) (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4A\u003C\/a\u003E, Table S5\u003C\/strong\u003E) \u003Csup\u003E\u003Ca id=\u0022xref-ref-40-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-40\u0022\u003E40\u003C\/a\u003E\u2013\u003Ca id=\u0022xref-ref-42-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-42\u0022\u003E42\u003C\/a\u003E\u003C\/sup\u003E. Additional genes found upregulated in the pre-hot subcluster are involved in critical biological pathways, including immunity, innate and adaptive immunity, host-virus interactions, and inflammatory and antiviral responses. They are part of secretion systems (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4D-E\u003C\/a\u003E\u003C\/strong\u003E). Strikingly, the pre-cold subcluster had conserved pathways associated with antiviral response and innate immunity while showing reduced enrichment of those related to immune and inflammatory responses (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4D-E\u003C\/a\u003E\u003C\/strong\u003E).\u003C\/p\u003E\u003Cdiv id=\u0022F4\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F4.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Analysis of gene expression patterns within the pre- and post-DAA groups revealed distinct individual responses to HCV infection and DAA therapy Within patients infected with HCV and then treated with DAA, we identified different subclusters in the heat map (see Fig 2A). Four different groups were compared: the Pre-hot (high gene expression profile Pre-DAA therapy compared to controls), Pre-cold (low gene expression profile Pre-DAA therapy compared to controls), Post-hot (high gene expression Post-DAA therapy comparable to Pre-hot), and Post-cold (low gene expression Post-DAA therapy comparable to controls). Volcano plots were used to compare the gene expression profiles of liver biopsies from (A) patients pre-hot versus pre-cold and (B) patients post-hot versus post-cold. (C) The Venn diagram illustrates significantly expressed genes across pre-cold, pre-hot, and post-hot patients and their overlap. Out of the total 197 differentially expressed genes (the pre-hot expressing 162 genes), 54 overlap between the post-hot and pre-hot, while seven overlap between the pre-cold and pre-hot. In addition, the pre-cold showed a gene expression pattern most like the controls, as it had the fewest significant genes (7 genes) compared to the other groups. (D-E) Differential gene expression obtained from comparing pre-hot, pre-cold, and post-hot groups versus liver controls (see Fig S3-S4 and Table S4-S11) were used to determine enriched pathways using DAVID software and the Reactome database. The y-axis represents the top enriched pathways. The color of the dots represents the \u0026#x2212;Log10 of the adjusted p-value obtained from the enrichment analysis. \u0026#x2013;Log10 \u0026gt; 2 (adjusted p-value= \u0026#x2264;0.01) indicates significant enrichment (yellow dots represent higher significance). Compared to the pre-hot group, the post-hot group was characterized by the activation of persistent immune and inflammatory response pathways without activating antiviral genes and MHC I pathways. (F-G) Gene expression was analyzed using CIBERSORT to estimate the relative proportions of different immune cell types in controls and pre- and post-DAA treatment groups (pre-hot, pre-cold, post-hot, and post-cold). Patients pre-hot showed enrichment of M1 cells, and patients post-hot had an increased proportion of na\u0026#xEF;ve B cells (light yellow) and activated NK cells (blue). Specific macrophage (M1 and M2), T and B cells, and NK cells genes enriched in each group are shown in Fig S1A-B with corresponding laboratory values in Fig S2. Additional Volcano plots showing different comparisons between groups and contributing genes are shown in Fig S3 and Table S4-S11. Normal distribution was tested, and a one-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1289227155\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Analysis of gene expression patterns within the pre- and post-DAA groups revealed distinct individual responses to HCV infection and DAA therapy\u0026lt;\/span\u0026gt; Within patients infected with HCV and then treated with DAA, we identified different subclusters in the heat map (see \u0026lt;strong\u0026gt;Fig 2A\u0026lt;\/strong\u0026gt;). Four different groups were compared: the Pre-hot (high gene expression profile Pre-DAA therapy compared to controls), Pre-cold (low gene expression profile Pre-DAA therapy compared to controls), Post-hot (high gene expression Post-DAA therapy comparable to Pre-hot), and Post-cold (low gene expression Post-DAA therapy comparable to controls). Volcano plots were used to compare the gene expression profiles of liver biopsies from (\u0026lt;strong\u0026gt;A\u0026lt;\/strong\u0026gt;) patients pre-hot versus pre-cold and (\u0026lt;strong\u0026gt;B\u0026lt;\/strong\u0026gt;) patients post-hot versus post-cold. (\u0026lt;strong\u0026gt;C\u0026lt;\/strong\u0026gt;) The Venn diagram illustrates significantly expressed genes across pre-cold, pre-hot, and post-hot patients and their overlap. Out of the total 197 differentially expressed genes (the pre-hot expressing 162 genes), 54 overlap between the post-hot and pre-hot, while seven overlap between the pre-cold and pre-hot. In addition, the pre-cold showed a gene expression pattern most like the controls, as it had the fewest significant genes (7 genes) compared to the other groups. (\u0026lt;strong\u0026gt;D-E\u0026lt;\/strong\u0026gt;) Differential gene expression obtained from comparing pre-hot, pre-cold, and post-hot groups versus liver controls (\u0026lt;strong\u0026gt;see Fig S3-S4 and Table S4-S11\u0026lt;\/strong\u0026gt;) were used to determine enriched pathways using DAVID software and the Reactome database. The y-axis represents the top enriched pathways. The color of the dots represents the \u0026#x2212;Log10 of the adjusted p-value obtained from the enrichment analysis. \u0026#x2013;Log10 \u0026gt; 2 (adjusted p-value= \u0026#x2264;0.01) indicates significant enrichment (yellow dots represent higher significance). Compared to the pre-hot group, the post-hot group was characterized by the activation of persistent immune and inflammatory response pathways without activating antiviral genes and MHC I pathways. (\u0026lt;strong\u0026gt;F-G\u0026lt;\/strong\u0026gt;) Gene expression was analyzed using CIBERSORT to estimate the relative proportions of different immune cell types in controls and pre- and post-DAA treatment groups (pre-hot, pre-cold, post-hot, and post-cold). Patients pre-hot showed enrichment of M1 cells, and patients post-hot had an increased proportion of na\u0026#xEF;ve B cells (light yellow) and activated NK cells (blue). Specific macrophage (M1 and M2), T and B cells, and NK cells genes enriched in each group are shown in \u0026lt;strong\u0026gt;Fig S1A-B\u0026lt;\/strong\u0026gt; with corresponding laboratory values in \u0026lt;strong\u0026gt;Fig S2\u0026lt;\/strong\u0026gt;. Additional Volcano plots showing different comparisons between groups and contributing genes are shown in \u0026lt;strong\u0026gt;Fig S3\u0026lt;\/strong\u0026gt; and \u0026lt;strong\u0026gt;Table S4-S11\u0026lt;\/strong\u0026gt;. Normal distribution was tested, and a one-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 4.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F4.medium.gif\u0022 width=\u0022351\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 4.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F4.medium.gif\u0022 width=\u0022351\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F4.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 4.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F4.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 4.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EAnalysis of gene expression patterns within the pre- and post-DAA groups revealed distinct individual responses to HCV infection and DAA therapy\u003C\/span\u003E\u003Cp id=\u0022p-39\u0022 class=\u0022first-child\u0022\u003EWithin patients infected with HCV and then treated with DAA, we identified different subclusters in the heat map (see \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-7\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig 2A\u003C\/a\u003E\u003C\/strong\u003E). Four different groups were compared: the Pre-hot (high gene expression profile Pre-DAA therapy compared to controls), Pre-cold (low gene expression profile Pre-DAA therapy compared to controls), Post-hot (high gene expression Post-DAA therapy comparable to Pre-hot), and Post-cold (low gene expression Post-DAA therapy comparable to controls). Volcano plots were used to compare the gene expression profiles of liver biopsies from (\u003Cstrong\u003EA\u003C\/strong\u003E) patients pre-hot versus pre-cold and (\u003Cstrong\u003EB\u003C\/strong\u003E) patients post-hot versus post-cold. (\u003Cstrong\u003EC\u003C\/strong\u003E) The Venn diagram illustrates significantly expressed genes across pre-cold, pre-hot, and post-hot patients and their overlap. Out of the total 197 differentially expressed genes (the pre-hot expressing 162 genes), 54 overlap between the post-hot and pre-hot, while seven overlap between the pre-cold and pre-hot. In addition, the pre-cold showed a gene expression pattern most like the controls, as it had the fewest significant genes (7 genes) compared to the other groups. (\u003Cstrong\u003ED-E\u003C\/strong\u003E) Differential gene expression obtained from comparing pre-hot, pre-cold, and post-hot groups versus liver controls (\u003Cstrong\u003Esee Fig S3-S4 and Table S4-S11\u003C\/strong\u003E) were used to determine enriched pathways using DAVID software and the Reactome database. The y-axis represents the top enriched pathways. The color of the dots represents the \u2212Log10 of the adjusted p-value obtained from the enrichment analysis. \u2013Log10 \u0026gt; 2 (adjusted p-value= \u22640.01) indicates significant enrichment (yellow dots represent higher significance). Compared to the pre-hot group, the post-hot group was characterized by the activation of persistent immune and inflammatory response pathways without activating antiviral genes and MHC I pathways. (\u003Cstrong\u003EF-G\u003C\/strong\u003E) Gene expression was analyzed using CIBERSORT to estimate the relative proportions of different immune cell types in controls and pre- and post-DAA treatment groups (pre-hot, pre-cold, post-hot, and post-cold). Patients pre-hot showed enrichment of M1 cells, and patients post-hot had an increased proportion of na\u00efve B cells (light yellow) and activated NK cells (blue). Specific macrophage (M1 and M2), T and B cells, and NK cells genes enriched in each group are shown in \u003Cstrong\u003EFig S1A-B\u003C\/strong\u003E with corresponding laboratory values in \u003Cstrong\u003EFig S2\u003C\/strong\u003E. Additional Volcano plots showing different comparisons between groups and contributing genes are shown in \u003Cstrong\u003EFig S3\u003C\/strong\u003E and \u003Cstrong\u003ETable S4-S11\u003C\/strong\u003E. Normal distribution was tested, and a one-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-40\u0022\u003ESimilarly, we compared the gene expression patterns of post-DAA patients with high expression (post-hot; pt 6,12,22; n = 3), who clustered with pre-hot patients, to those patients who received DAA and clustered near the control group (post-cold; pt 1, 5, 7-11, 13, 19-21; n = 11) (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-8\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2B\u003C\/a\u003E\u003C\/strong\u003E). Except for TGF\u03b21 (associated with anti-inflammatory\/profibrotic responses) and CD24 (plays a role in cancer proliferation), the other genes in the post-hot patients were significantly downregulated compared with the post-cold group. Cluster analysis of these genes using string indicated the downregulation of complement cascade components (C8B, CFB, C1S, SERPING1, C3, CD46, CD81, CD40) and fibroblast proliferation (PDGFC, BMI1, FN1, SMAD2) (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-7\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4B\u003C\/a\u003E, Table S8\u003C\/strong\u003E). Only the post-hot patients showed significant expression (up\/downregulated, 88 genes) compared to controls (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-8\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4C\u003C\/a\u003E; Fig. S3B; Fig. S4B; Table S9\u003C\/strong\u003E). Interestingly, post-hot patients showed an overall downregulation of immune pathways, especially those associated with adaptive immunity, antiviral defense, and MHC I antigen presentation (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-9\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4D-E\u003C\/a\u003E\u003C\/strong\u003E). Significantly regulated genes identified in other comparisons (i.e., pre-hot vs. post-cold patients, post-cold vs. controls) are also shown (\u003Cstrong\u003EFig. S3, Tables S10-11).\u003C\/strong\u003E Specific cell populations were not significantly enriched when comparing the pre-hot to pre-cold or post-hot to post-cold patients; only the pre-hot subcluster shared the same cell pattern initially observed in the pre-DAA treatment group, which consisted of significantly reduced monocytes and increased pro-inflammatory (M1) macrophages that decreased after DAA treatment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-10\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4F-G\u003C\/a\u003E, \u003Ca id=\u0022xref-fig-3-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3A, B\u003C\/a\u003E\u003C\/strong\u003E). Post-hot patients showed increased NK and na\u00efve B cell activation (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-11\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4F-G\u003C\/a\u003E\u003C\/strong\u003E). The genes responsible for M1 macrophage and B and NK cell enrichment in the pre-hot cluster are shown in the heatmap (\u003Cstrong\u003EFig. S1B)\u003C\/strong\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-41\u0022\u003ENext, we dissected the genes responsible for the identified enriched biological pathways. The heat map in \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-5-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EFig. 5\u003C\/a\u003E\u003C\/strong\u003E highlights and summarizes the activated genes and the associated pathways in each subcluster group compared to the controls. As previously mentioned, the pre-hot cluster generally had more robust gene upregulation than the pre-cold group, which had enrichment of type I\/III interferons and anti-viral response pathways. While the pre-hot patients had more than 18 genes (e.g., ISG15\/20, CD8A, IRF4, MX1, LTB, CXCL9\/10, IFI27, CCL19, CD27\/TNFRSF7, SAA1) with a log2 fold change \u0026gt; 2 when compared to controls (\u003Cstrong\u003ETable S6\u003C\/strong\u003E), the pre-cold patients only had three genes (ISG15, IFI27, and MX1) (\u003Cstrong\u003ETable S7\u003C\/strong\u003E). Interestingly, the log2 ratios of ISG15, IFI27, and MX1 between the two pre-DAA subclusters were 1.32, 1.17, and 1.26, respectively. All the patients post-DAA achieved SVR and had substantially decreased expression of genes related to innate immune and antiviral responses. However, the post-hot patients maintained mixed activation of critical inflammatory (e.g., TNF, TLRs, and NFLB) and anti-inflammatory\/profibrotic (e.g., TGF\u03b2, IL4, IL-13, and STAT6) pathways.\u003C\/p\u003E\u003Cdiv id=\u0022F5\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F5.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Gene expression patterns reveal distinct inflammatory and fibrogenic signaling pathways despite DAA therapy We selected differentially expressed genes from Tables S6-7, 9, 11 (pre-hot, pre-cold, post-hot, and post-cold groups compared to controls). We conducted a STRING network analysis based on these genes to cluster them according to their dominant functional pathway (lowest false discovery rate (FDR)) using an MCL clustering algorithm with an inflation of 5. Subsequently, we generated a heat map using the average Z-score value (intensity range: \u0026#xB1;2) for each group. The red boxes represent the clusters of the genes from the more relevant pathways. Viral response and MHC-I markers were upregulated exclusively in the pre-DAA therapy groups (Pre-hot and Pre-cold). Inflammation signals for both pre-hot and pre-cold were associated with type I interferon and TNF\/NFkB signaling pathways, with a lower gene expression in the pre-cold group. Conversely, the post-hot group displayed an upregulation pattern associated with IGF-1, IL-4\/IL-13-STAT6 alongside TNF\/NFkB signaling. Notably, anti-inflammatory and fibrogenic markers such as TGF-beta 1\/2 and ITGB3 were significantly expressed in the post-hot group. Abbreviations: Pre-hot (patients with high gene expression pre-DAA treatment), Pre-Cold (patients with low gene expression pre-DAA treatment), Post-Hot (patients with high gene expression post-DAA treatment), Post-Cold (patients with low expression post-DAA treatment), Ctrl (controls).\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1289227155\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Gene expression patterns reveal distinct inflammatory and fibrogenic signaling pathways despite DAA therapy\u0026lt;\/span\u0026gt; We selected differentially expressed genes from \u0026lt;strong\u0026gt;Tables S6-7, 9, 11\u0026lt;\/strong\u0026gt; (pre-hot, pre-cold, post-hot, and post-cold groups compared to controls). We conducted a STRING network analysis based on these genes to cluster them according to their dominant functional pathway (lowest false discovery rate (FDR)) using an MCL clustering algorithm with an inflation of 5. Subsequently, we generated a heat map using the average Z-score value (intensity range: \u0026#xB1;2) for each group. The red boxes represent the clusters of the genes from the more relevant pathways. Viral response and MHC-I markers were upregulated exclusively in the pre-DAA therapy groups (Pre-hot and Pre-cold). Inflammation signals for both pre-hot and pre-cold were associated with type I interferon and TNF\/NFkB signaling pathways, with a lower gene expression in the pre-cold group. Conversely, the post-hot group displayed an upregulation pattern associated with IGF-1, IL-4\/IL-13-STAT6 alongside TNF\/NFkB signaling. Notably, anti-inflammatory and fibrogenic markers such as TGF-beta 1\/2 and ITGB3 were significantly expressed in the post-hot group. Abbreviations: Pre-hot (patients with high gene expression pre-DAA treatment), Pre-Cold (patients with low gene expression pre-DAA treatment), Post-Hot (patients with high gene expression post-DAA treatment), Post-Cold (patients with low expression post-DAA treatment), Ctrl (controls).\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 5.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F5.medium.gif\u0022 width=\u0022205\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 5.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F5.medium.gif\u0022 width=\u0022205\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F5.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 5.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F5.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 5.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EGene expression patterns reveal distinct inflammatory and fibrogenic signaling pathways despite DAA therapy\u003C\/span\u003E\u003Cp id=\u0022p-42\u0022 class=\u0022first-child\u0022\u003EWe selected differentially expressed genes from \u003Cstrong\u003ETables S6-7, 9, 11\u003C\/strong\u003E (pre-hot, pre-cold, post-hot, and post-cold groups compared to controls). We conducted a STRING network analysis based on these genes to cluster them according to their dominant functional pathway (lowest false discovery rate (FDR)) using an MCL clustering algorithm with an inflation of 5. Subsequently, we generated a heat map using the average Z-score value (intensity range: \u00b12) for each group. The red boxes represent the clusters of the genes from the more relevant pathways. Viral response and MHC-I markers were upregulated exclusively in the pre-DAA therapy groups (Pre-hot and Pre-cold). Inflammation signals for both pre-hot and pre-cold were associated with type I interferon and TNF\/NFkB signaling pathways, with a lower gene expression in the pre-cold group. Conversely, the post-hot group displayed an upregulation pattern associated with IGF-1, IL-4\/IL-13-STAT6 alongside TNF\/NFkB signaling. Notably, anti-inflammatory and fibrogenic markers such as TGF-beta 1\/2 and ITGB3 were significantly expressed in the post-hot group. Abbreviations: Pre-hot (patients with high gene expression pre-DAA treatment), Pre-Cold (patients with low gene expression pre-DAA treatment), Post-Hot (patients with high gene expression post-DAA treatment), Post-Cold (patients with low expression post-DAA treatment), Ctrl (controls).\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-16\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ESpatial analysis showed that anti-inflammatory macrophages are the predominant phenotype in the hepatic microenvironment after DAA therapy\u003C\/h3\u003E\u003Cp id=\u0022p-43\u0022\u003EAt the gene level, inflammatory macrophages (M1) were significantly increased during HCV infection and decreased after DAA treatment. There was marked heterogeneity among the different groups, and some patients had persistent lymphocytic inflammation (MHAI) in their liver biopsies (\u003Cstrong\u003ETable 1\u003C\/strong\u003E). To evaluate individual patients and preserve the spatial context, we used spectral imaging to determine the primary macrophage phenotypes in the hepatic microenvironment before and after DAAs at the protein level. Unstained liver biopsies from controls and patients pre- and post-DAA treatment (\u003Cstrong\u003ETable 1, pt 1-8\u003C\/strong\u003E; \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-1-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFig 1A\u003C\/a\u003E, Study patient set 2\u003C\/strong\u003E) were stained with a macrophage multiplex panel (CD68, CD14, CD16, CD163, Mac 387, and DAPI). Representative multiplex images from controls (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-6-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFig. 6A, B\u003C\/a\u003E\u003C\/strong\u003E), a patient without persistent inflammation post-treatment (pt 6, MHAI = 0\/18) \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-6-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFig. 6C, D\u003C\/a\u003E\u003C\/strong\u003E), and a patient with persistent inflammation post-treatment (pt 2, MHAI = 4\/18; \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-6-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFig. 6E, F\u003C\/a\u003E\u003C\/strong\u003E) are shown. Consistent with our previous studies in steatotic liver disease and HCV, we observed higher expression of CD14+ phenotypes in the controls, which decreased during infection and even further after DAA treatment (p\u0026lt;0.001) (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-6-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFig. 6G\u003C\/a\u003E\u003C\/strong\u003E)\u003Csup\u003E\u003Ca id=\u0022xref-ref-36-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-36\u0022\u003E36\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-43-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-43\u0022\u003E43\u003C\/a\u003E\u003C\/sup\u003E. A significant (p\u0026lt;0.05) increase in the proportion of resident (CD68+ and CD68+\/CD163+) and monocyte-derived, pro-inflammatory macrophages (Mac387+, CD68+\/CD14+) was observed before DAA treatment in the hepatic microenvironment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-6-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFig. 6H\u003C\/a\u003E\u003C\/strong\u003E). The monocyte-derived and inflammatory (Mac387+, CD68+\/Mac387+) populations persisted post-DAA (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-6-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFig. 6H\u003C\/a\u003E)\u003C\/strong\u003E. After DAA treatment and SVR, a significant (p\u0026lt;0.05) increase in anti-inflammatory macrophages was observed when compared to controls (CD16+, CD16+\/CD163+, CD16+\/CD68+) (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-6-7\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFig. 6I\u003C\/a\u003E\u003C\/strong\u003E).\u003C\/p\u003E\u003Cdiv id=\u0022F6\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F6.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Comparison of macrophage phenotypes in liver biopsies from patients pre- and post-DAA therapy for HCV show a dominant anti-inflammatory response post-DAA Biopsies were stained with the macrophage multiplex panel (CD68, CD14, CD16, CD163, Mac 387, and DAPI), and images from stained slides were acquired using the Vectra 3 automated quantitative pathology imaging system. Representative multiplex images from controls (A, B), a patient (pt 6) without persistent inflammation post-treatment (C, D), and a patient (pt 2) with persistent inflammation post-treatment (E, F) are shown. (A, B) Control patients had more CD14+ cells that decreased with HCV infection and even further post-treatment. (C, E) Patients with HCV pre-DAA treatment had increased inflammatory macrophages (CD68+, CD14+, Mac387+, CD68+\/Mac387+, and CD68+\/CD14+), which decreased post-treatment (D), except for pt 2 which had persistent inflammation post-treatment (F). Patients with persistent inflammation had increased anti-inflammatory CD16+ and CD16+CD163+ post-treatment. (G-I) Shows statistical comparisons of the different phenotypes identified in the control, pre-, and post-treatment groups. Images were acquired at 20x. *Statistical test: non-parametric Wilcoxon rank-sum test, with adj. p\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1289227155\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Comparison of macrophage phenotypes in liver biopsies from patients pre- and post-DAA therapy for HCV show a dominant anti-inflammatory response post-DAA\u0026lt;\/span\u0026gt; Biopsies were stained with the macrophage multiplex panel (CD68, CD14, CD16, CD163, Mac 387, and DAPI), and images from stained slides were acquired using the Vectra 3 automated quantitative pathology imaging system. Representative multiplex images from controls (\u0026lt;strong\u0026gt;A, B\u0026lt;\/strong\u0026gt;), a patient (pt 6) without persistent inflammation post-treatment (\u0026lt;strong\u0026gt;C, D),\u0026lt;\/strong\u0026gt; and a patient (pt 2) with persistent inflammation post-treatment (\u0026lt;strong\u0026gt;E, F\u0026lt;\/strong\u0026gt;) are shown. (\u0026lt;strong\u0026gt;A, B\u0026lt;\/strong\u0026gt;) Control patients had more CD14+ cells that decreased with HCV infection and even further post-treatment. (\u0026lt;strong\u0026gt;C, E\u0026lt;\/strong\u0026gt;) Patients with HCV pre-DAA treatment had increased inflammatory macrophages (CD68+, CD14+, Mac387+, CD68+\/Mac387+, and CD68+\/CD14+), which decreased post-treatment (\u0026lt;strong\u0026gt;D\u0026lt;\/strong\u0026gt;), except for pt 2 which had persistent inflammation post-treatment (\u0026lt;strong\u0026gt;F\u0026lt;\/strong\u0026gt;). Patients with persistent inflammation had increased anti-inflammatory CD16+ and CD16+CD163+ post-treatment. (\u0026lt;strong\u0026gt;G-I\u0026lt;\/strong\u0026gt;) Shows statistical comparisons of the different phenotypes identified in the control, pre-, and post-treatment groups. Images were acquired at 20x. *Statistical test: non-parametric Wilcoxon rank-sum test, with adj. p\u0026lt;0.05, was used for significance.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 6.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F6.medium.gif\u0022 width=\u0022340\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 6.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F6.medium.gif\u0022 width=\u0022340\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F6.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 6.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F6.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 6.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EComparison of macrophage phenotypes in liver biopsies from patients pre- and post-DAA therapy for HCV show a dominant anti-inflammatory response post-DAA\u003C\/span\u003E\u003Cp id=\u0022p-44\u0022 class=\u0022first-child\u0022\u003EBiopsies were stained with the macrophage multiplex panel (CD68, CD14, CD16, CD163, Mac 387, and DAPI), and images from stained slides were acquired using the Vectra 3 automated quantitative pathology imaging system. Representative multiplex images from controls (\u003Cstrong\u003EA, B\u003C\/strong\u003E), a patient (pt 6) without persistent inflammation post-treatment (\u003Cstrong\u003EC, D),\u003C\/strong\u003E and a patient (pt 2) with persistent inflammation post-treatment (\u003Cstrong\u003EE, F\u003C\/strong\u003E) are shown. (\u003Cstrong\u003EA, B\u003C\/strong\u003E) Control patients had more CD14+ cells that decreased with HCV infection and even further post-treatment. (\u003Cstrong\u003EC, E\u003C\/strong\u003E) Patients with HCV pre-DAA treatment had increased inflammatory macrophages (CD68+, CD14+, Mac387+, CD68+\/Mac387+, and CD68+\/CD14+), which decreased post-treatment (\u003Cstrong\u003ED\u003C\/strong\u003E), except for pt 2 which had persistent inflammation post-treatment (\u003Cstrong\u003EF\u003C\/strong\u003E). Patients with persistent inflammation had increased anti-inflammatory CD16+ and CD16+CD163+ post-treatment. (\u003Cstrong\u003EG-I\u003C\/strong\u003E) Shows statistical comparisons of the different phenotypes identified in the control, pre-, and post-treatment groups. Images were acquired at 20x. *Statistical test: non-parametric Wilcoxon rank-sum test, with adj. p\u0026lt;0.05, was used for significance.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-17\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ESpatial imaging and t-SNE plots highlighted differences in T cell populations before and after DAA therapy\u003C\/h3\u003E\u003Cp id=\u0022p-45\u0022\u003EThe presence of marked individual patient heterogeneity in Log2 levels of T cell markers (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3\u003C\/a\u003E\u003C\/strong\u003E) prompted us to evaluate the patients individually using spectral imaging. We and others have reported the presence of persistent portal lymphocytic inflammation post-DAA treatment despite a significant reduction in the overall inflammatory activity after clearing the HCV with DAAs\u003Csup\u003E\u003Ca id=\u0022xref-ref-23-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-23\u0022\u003E23\u003C\/a\u003E\u2013\u003Ca id=\u0022xref-ref-25-6\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-44-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-44\u0022\u003E44\u003C\/a\u003E\u003C\/sup\u003E. Slides were stained using a multiplex T cell panel (CD3, CD4, CD8, CD45RO, FoxP3, and DAPI; \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-1-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFig.1A\u003C\/a\u003E, Study patient set 3\u003C\/strong\u003E), and multicomponent TIFF images were uploaded to Visiopharm for analysis using custom-designed algorithms. A detailed phenotype map with the number of positive cells per area shows heterogeneity of T cell phenotypes in individual patients before (pt 5, 8, 12, 13) and after (pt 1, 3, 5, 8, 12, 13) treatment compared to controls is shown (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-7-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig 7A\u003C\/a\u003E\u003C\/strong\u003E). Liver biopsies with an MHAI \u003Cspan class=\u0022underline\u0022\u003E\u0026gt;\u003C\/span\u003E 2 (pt 1, 8, 12,13) were considered to have persistent inflammation after treatment, while liver biopsies with an MHAI \u003Cspan class=\u0022underline\u0022\u003E\u0026lt;\u003C\/span\u003E 1 (pt 3, 5) were considered not to have persistent inflammation (see \u003Cstrong\u003ETable 1\u003C\/strong\u003E). Before and after treatment, there was marked heterogeneity in T cell phenotypes (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-7-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7A\u003C\/a\u003E\u003C\/strong\u003E). CD8+ phenotypes were more frequent in the patients pre-DAA (i.e., CD8+, CD3+\/CD8+, CD8+\/CD45RO+, CD3+\/CD8+\/CD45RO+). Infiltration of some of these T cell phenotypes (e.g., CD3+CD8+) agreed with the increased expression of the CD8A gene observed in patients before treatment (see \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3D\u003C\/a\u003E)\u003C\/strong\u003E. Helper T cells (CD3+\/CD4+) were also observed pre-DAA. Still, they were more frequent in patients post-DAA treatment (i.e., CD4+, CD3+\/CD4+, CD4+\/CD45RO+, CD3+\/CD4+\/CD45RO+) (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-7-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7A\u003C\/a\u003E\u003C\/strong\u003E). Patient 13 had the highest inflammatory activity score before DAAs (MHAI: 5\/18; Fibrosis stage: 5\/6) and had the highest prevalence of cytotoxic and regulatory T cell phenotypes (e.g., CD3+\/CD8+, CD3+\/CD8+\/CD45RO+, CD3+\/CD8+\/FoxP3+). The prevalence of these phenotypes remained high after treatment, even though light microscopy appeared to show an absence of persistent inflammation. The patient (pt 1, MHAI: 5\/18; Fibrosis stage: 2-3\/6) with the highest MHAI after DAAs had increased memory (i.e., CD3+, CD45RO+, CD3\/CD45RO+) and helper T cell (i.e., CD3+\/CD4+ and CD3+\/CD4+\/CD45RO+) phenotypes. CD4+ phenotypes were also substantially increased in patients with persistent inflammation (pt 1, 8; \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-7-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7A\u003C\/a\u003E\u003C\/strong\u003E).\u003C\/p\u003E\u003Cdiv id=\u0022F7\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F7.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Analysis of T cell phenotypes in liver biopsies from patients pre- and post-DAA therapy for HCV shows heterogeneity between individual patients (A) Unstained slides were stained with the multiplex T cell panel (CD3+, CD4+, CD8+, CD45RO+, FoxP3+, and DAPI). Multicomponent TIFF images were analyzed with Visiopharm using optimized custom AI applications to determine the type and number of T cell phenotypes in the hepatic microenvironment (controls, n = 2; patients with HCV pre-DAA, n = 4; and post-DAA, n = 6). (A) The number of phenotypes identified in individual controls and patients with HCV pre- and post-DAA are shown. Variable enrichment of T cells (CD3+), memory T cells (CD45RO+), and cytotoxic T cells (CD3+\/CD8+) were observed in patients pre-DAA (pt 5, 8, 12, 13) compared to patients post-DAA treatment with (pt 1,8,12,13; MHAI \u0026gt; 2) and without (pt 3, 5; MHAI \u0026lt; 1) persistent inflammation. (B-E) Representative H\u0026amp;E images, phenotypes, and t-SNE plots from controls, patients with HCV pre-DAA, and patients post-DAA with and without persistent inflammation are shown. H\u0026amp;E images were used to evaluate MHAI and fibrosis stages. As illustrated in the phenotype images and tSNE plots, the controls and patients post-DAA therapy without persistent inflammation (B, E) had low infiltration and diversity of T cell phenotypes compared to patients with HCV pre-DAA therapy (C) and post-DAA with persistent inflammation (D) (i.e., chronic HCV pre-DAA treatment had increased infiltration of CD3+CD45RO+ (yellow) and patients post-DAA with persistent inflammation had increased CD3+CD4+CD45RO+ (dark pink phenotypes). Each colored dot represents a unique cellular phenotype, and gray dots represent negative cells for all the markers evaluated. MHAI: modified hepatitis activity index; AI, artificial intelligence.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1289227155\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Analysis of T cell phenotypes in liver biopsies from patients pre- and post-DAA therapy for HCV shows heterogeneity between individual patients\u0026lt;\/span\u0026gt; (\u0026lt;strong\u0026gt;A\u0026lt;\/strong\u0026gt;) Unstained slides were stained with the multiplex T cell panel (CD3+, CD4+, CD8+, CD45RO+, FoxP3+, and DAPI). Multicomponent TIFF images were analyzed with Visiopharm using optimized custom AI applications to determine the type and number of T cell phenotypes in the hepatic microenvironment (controls, n = 2; patients with HCV pre-DAA, n = 4; and post-DAA, n = 6). \u0026lt;strong\u0026gt;(A)\u0026lt;\/strong\u0026gt; The number of phenotypes identified in individual controls and patients with HCV pre- and post-DAA are shown. Variable enrichment of T cells (CD3+), memory T cells (CD45RO+), and cytotoxic T cells (CD3+\/CD8+) were observed in patients pre-DAA (pt 5, 8, 12, 13) compared to patients post-DAA treatment with (pt 1,8,12,13; MHAI \u0026gt; 2) and without (pt 3, 5; MHAI \u0026lt; 1) persistent inflammation. (\u0026lt;strong\u0026gt;B-E\u0026lt;\/strong\u0026gt;) Representative H\u0026amp;E images, phenotypes, and t-SNE plots from controls, patients with HCV pre-DAA, and patients post-DAA with and without persistent inflammation are shown. H\u0026amp;E images were used to evaluate MHAI and fibrosis stages. As illustrated in the phenotype images and tSNE plots, the controls and patients post-DAA therapy without persistent inflammation (\u0026lt;strong\u0026gt;B\u0026lt;\/strong\u0026gt;, \u0026lt;strong\u0026gt;E\u0026lt;\/strong\u0026gt;) had low infiltration and diversity of T cell phenotypes compared to patients with HCV pre-DAA therapy (\u0026lt;strong\u0026gt;C\u0026lt;\/strong\u0026gt;) and post-DAA with persistent inflammation (\u0026lt;strong\u0026gt;D\u0026lt;\/strong\u0026gt;) (i.e., chronic HCV pre-DAA treatment had increased infiltration of CD3+CD45RO+ (yellow) and patients post-DAA with persistent inflammation had increased CD3+CD4+CD45RO+ (dark pink phenotypes). Each colored dot represents a unique cellular phenotype, and gray dots represent negative cells for all the markers evaluated. MHAI: modified hepatitis activity index; AI, artificial intelligence.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 7.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F7.medium.gif\u0022 width=\u0022335\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 7.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F7.medium.gif\u0022 width=\u0022335\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F7.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 7.\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F7.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 7.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EAnalysis of T cell phenotypes in liver biopsies from patients pre- and post-DAA therapy for HCV shows heterogeneity between individual patients\u003C\/span\u003E\u003Cp id=\u0022p-46\u0022 class=\u0022first-child\u0022\u003E(\u003Cstrong\u003EA\u003C\/strong\u003E) Unstained slides were stained with the multiplex T cell panel (CD3+, CD4+, CD8+, CD45RO+, FoxP3+, and DAPI). Multicomponent TIFF images were analyzed with Visiopharm using optimized custom AI applications to determine the type and number of T cell phenotypes in the hepatic microenvironment (controls, n = 2; patients with HCV pre-DAA, n = 4; and post-DAA, n = 6). \u003Cstrong\u003E(A)\u003C\/strong\u003E The number of phenotypes identified in individual controls and patients with HCV pre- and post-DAA are shown. Variable enrichment of T cells (CD3+), memory T cells (CD45RO+), and cytotoxic T cells (CD3+\/CD8+) were observed in patients pre-DAA (pt 5, 8, 12, 13) compared to patients post-DAA treatment with (pt 1,8,12,13; MHAI \u0026gt; 2) and without (pt 3, 5; MHAI \u0026lt; 1) persistent inflammation. (\u003Cstrong\u003EB-E\u003C\/strong\u003E) Representative H\u0026amp;E images, phenotypes, and t-SNE plots from controls, patients with HCV pre-DAA, and patients post-DAA with and without persistent inflammation are shown. H\u0026amp;E images were used to evaluate MHAI and fibrosis stages. As illustrated in the phenotype images and tSNE plots, the controls and patients post-DAA therapy without persistent inflammation (\u003Cstrong\u003EB\u003C\/strong\u003E, \u003Cstrong\u003EE\u003C\/strong\u003E) had low infiltration and diversity of T cell phenotypes compared to patients with HCV pre-DAA therapy (\u003Cstrong\u003EC\u003C\/strong\u003E) and post-DAA with persistent inflammation (\u003Cstrong\u003ED\u003C\/strong\u003E) (i.e., chronic HCV pre-DAA treatment had increased infiltration of CD3+CD45RO+ (yellow) and patients post-DAA with persistent inflammation had increased CD3+CD4+CD45RO+ (dark pink phenotypes). Each colored dot represents a unique cellular phenotype, and gray dots represent negative cells for all the markers evaluated. MHAI: modified hepatitis activity index; AI, artificial intelligence.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-47\u0022\u003ESurprisingly, several T cell phenotypes persisted in the hepatic microenvironment even when the biopsy did not appear to have persistent inflammation by light microscopy (pt 5; \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-7-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7A, B\u003C\/a\u003E; Fig. S5A\u003C\/strong\u003E). Representative H\u0026amp;Es, phenotype profile maps, and t-SNE cluster plots (where each color represents a different T cell phenotype, and gray dots indicate cells that were negative for all T cell markers tested in the multiplex assay) are shown for comparison (Control; pre-DAA, pt 13), persistent inflammation (post-DAA, pt 1), without persistent inflammation (post-DAA, pt 5; \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-7-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7B-E\u003C\/a\u003E\u003C\/strong\u003E). Individual variation in the T cell phenotypes infiltrating the liver microenvironment of controls and patients pre-DAA and post-DAA treatment are shown in \u003Cstrong\u003EFig. S5A-B.\u003C\/strong\u003E\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-18\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EPatients who had higher baseline gene expression before DAA treatment had worse clinical outcomes after treatment\u003C\/h3\u003E\u003Cp id=\u0022p-48\u0022\u003ETwo different gene expression patterns were identified in the biopsies at baseline pre-DAA treatment: the pre-hot subcluster (nine out of 17, 52.9%; pt 10-14 and 19-22) with enriched gene expression and the pre-cold subcluster (eight out of 17, 47.1%; pt 5-8 and 15-18) with low gene expression compared to controls (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-9\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2\u003C\/a\u003E, \u003Ca id=\u0022xref-fig-4-12\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003E4\u003C\/a\u003E; Table S5-7\u003C\/strong\u003E). Except for the MHAI score (p \u0026lt; 0.01) and a trend toward increased fibrosis in the pre-hot subcluster, no statistically significant differences were observed in laboratory test results, viral load, virus genotype, and clinical data between the pre-hot and pre-cold subclusters (\u003Cstrong\u003EFig. S2 and Table 1\u003C\/strong\u003E).\u003C\/p\u003E\u003Cp id=\u0022p-49\u0022\u003EWe then explored whether the patients with different gene expression patterns pre-DAA treatment were associated with poor outcomes post-DAA therapy, defined as progression to cirrhosis, development of HCC, or death related to liver failure. We observed a significant association (Fisher test p\u0026lt;0.049) between poor outcomes and patients exhibiting the pre-hot pattern (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-8-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F8\u0022\u003EFig. 8A\u003C\/a\u003E\u003C\/strong\u003E). Four out of the nine pre-hot patients (44.4%; pt13, 19-20, and 22) developed cirrhosis, and three out of the nine pre hot (33.3%; pt 10, 14, and 19) died from complications of decompensated cirrhosis. Only one patient with the pre-cold pattern (one out of 8, 12.5%; pt 17) experienced a poor outcome (\u003Cstrong\u003ETable 1\u003C\/strong\u003E, \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-8-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F8\u0022\u003EFig. 8A\u003C\/a\u003E\u003C\/strong\u003E). The association of the patients with the pre-hot pattern and the poor outcomes is consistent with the enrichment of genes associated with cancer progression and increased inflammatory responses observed in this subcluster (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-13\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4A\u003C\/a\u003E, Table S5\u003C\/strong\u003E).\u003C\/p\u003E\u003Cdiv id=\u0022F8\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F8\/graphic-8.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Patients with HCV and increased gene expression show increased poor outcomes and correlated with fibrosis stage post-DAA treatment (A) A positive association of poor outcomes was observed in patients exhibiting the pre-hot pattern (6\/9) compared to those with the pre-cold pattern (1\/8). (B) Patients with increased gene expression (pre-hot; pt 10-13, 19-22) before treatment did not improve their fibrosis post-DAA, while it consistently remained low in the pre-cold group (pt 5-8). (C) Patients with poor outcomes had a significantly increased MHAI scores and fibrosis stages compared to patients with good outcomes. (D) Genes significantly (p1 are considered as a positive association. R2 values\u0026gt;0 suggest a positive correlation. Normal distribution was tested, and a one-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1289227155\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Patients with HCV and increased gene expression show increased poor outcomes and correlated with fibrosis stage post-DAA treatment\u0026lt;\/span\u0026gt; \u0026lt;strong\u0026gt;(A)\u0026lt;\/strong\u0026gt; A positive association of poor outcomes was observed in patients exhibiting the pre-hot pattern (6\/9) compared to those with the pre-cold pattern (1\/8). (\u0026lt;strong\u0026gt;B\u0026lt;\/strong\u0026gt;) Patients with increased gene expression (pre-hot; pt 10-13, 19-22) before treatment did not improve their fibrosis post-DAA, while it consistently remained low in the pre-cold group (pt 5-8). (\u0026lt;strong\u0026gt;C\u0026lt;\/strong\u0026gt;) Patients with poor outcomes had a significantly increased MHAI scores and fibrosis stages compared to patients with good outcomes. (\u0026lt;strong\u0026gt;D\u0026lt;\/strong\u0026gt;) Genes significantly (p\u0026lt;0.05) increased in the pre-hot subcluster (\u0026lt;strong\u0026gt;Table S5\u0026lt;\/strong\u0026gt;) compared to the pre-cold group correlated with fibrosis stage and MHI scores after treatment. Abbreviations: MHAI: modified hepatitis activity index. The x-axis represents the r\u0026lt;sup\u0026gt;2\u0026lt;\/sup\u0026gt;. The Fisher test determined the association between gene expression pre-DAA treatment and outcomes. OR ratios \u0026gt;1 are considered as a positive association. R\u0026lt;sup\u0026gt;2\u0026lt;\/sup\u0026gt; values\u0026gt;0 suggest a positive correlation. Normal distribution was tested, and a one-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 8.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F8\/graphic-8.medium.gif\u0022 width=\u0022376\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 8.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F8\/graphic-8.medium.gif\u0022 width=\u0022376\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F8\/graphic-8.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download \u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F8\/graphic-8.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F8\/graphic-9.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Patients with HCV and increased gene expression show increased poor outcomes and correlated with fibrosis stage post-DAA treatment (A) A positive association of poor outcomes was observed in patients exhibiting the pre-hot pattern (6\/9) compared to those with the pre-cold pattern (1\/8). (B) Patients with increased gene expression (pre-hot; pt 10-13, 19-22) before treatment did not improve their fibrosis post-DAA, while it consistently remained low in the pre-cold group (pt 5-8). (C) Patients with poor outcomes had a significantly increased MHAI scores and fibrosis stages compared to patients with good outcomes. (D) Genes significantly (p1 are considered as a positive association. R2 values\u0026gt;0 suggest a positive correlation. Normal distribution was tested, and a one-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001.\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-1289227155\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;\u0026lt;div xmlns=\u0026quot;http:\/\/www.w3.org\/1999\/xhtml\u0026quot;\u0026gt;\u0026lt;span class=\u0026quot;caption-title\u0026quot;\u0026gt;Patients with HCV and increased gene expression show increased poor outcomes and correlated with fibrosis stage post-DAA treatment\u0026lt;\/span\u0026gt; \u0026lt;strong\u0026gt;(A)\u0026lt;\/strong\u0026gt; A positive association of poor outcomes was observed in patients exhibiting the pre-hot pattern (6\/9) compared to those with the pre-cold pattern (1\/8). (\u0026lt;strong\u0026gt;B\u0026lt;\/strong\u0026gt;) Patients with increased gene expression (pre-hot; pt 10-13, 19-22) before treatment did not improve their fibrosis post-DAA, while it consistently remained low in the pre-cold group (pt 5-8). (\u0026lt;strong\u0026gt;C\u0026lt;\/strong\u0026gt;) Patients with poor outcomes had a significantly increased MHAI scores and fibrosis stages compared to patients with good outcomes. (\u0026lt;strong\u0026gt;D\u0026lt;\/strong\u0026gt;) Genes significantly (p\u0026lt;0.05) increased in the pre-hot subcluster (\u0026lt;strong\u0026gt;Table S5\u0026lt;\/strong\u0026gt;) compared to the pre-cold group correlated with fibrosis stage and MHI scores after treatment. Abbreviations: MHAI: modified hepatitis activity index. The x-axis represents the r\u0026lt;sup\u0026gt;2\u0026lt;\/sup\u0026gt;. The Fisher test determined the association between gene expression pre-DAA treatment and outcomes. OR ratios \u0026gt;1 are considered as a positive association. R\u0026lt;sup\u0026gt;2\u0026lt;\/sup\u0026gt; values\u0026gt;0 suggest a positive correlation. Normal distribution was tested, and a one-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001.\u0026lt;\/div\u0026gt;\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 8.\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F8\/graphic-9.medium.gif\u0022 width=\u0022440\u0022 height=\u0022341\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 8.\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F8\/graphic-9.medium.gif\u0022 width=\u0022440\u0022 height=\u0022341\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F8\/graphic-9.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download \u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2025\/02\/18\/2025.02.17.25321289\/F8\/graphic-9.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 8.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EPatients with HCV and increased gene expression show increased poor outcomes and correlated with fibrosis stage post-DAA treatment\u003C\/span\u003E\u003Cp id=\u0022p-50\u0022 class=\u0022first-child\u0022\u003E\u003Cstrong\u003E(A)\u003C\/strong\u003E A positive association of poor outcomes was observed in patients exhibiting the pre-hot pattern (6\/9) compared to those with the pre-cold pattern (1\/8). (\u003Cstrong\u003EB\u003C\/strong\u003E) Patients with increased gene expression (pre-hot; pt 10-13, 19-22) before treatment did not improve their fibrosis post-DAA, while it consistently remained low in the pre-cold group (pt 5-8). (\u003Cstrong\u003EC\u003C\/strong\u003E) Patients with poor outcomes had a significantly increased MHAI scores and fibrosis stages compared to patients with good outcomes. (\u003Cstrong\u003ED\u003C\/strong\u003E) Genes significantly (p\u0026lt;0.05) increased in the pre-hot subcluster (\u003Cstrong\u003ETable S5\u003C\/strong\u003E) compared to the pre-cold group correlated with fibrosis stage and MHI scores after treatment. Abbreviations: MHAI: modified hepatitis activity index. The x-axis represents the r\u003Csup\u003E2\u003C\/sup\u003E. The Fisher test determined the association between gene expression pre-DAA treatment and outcomes. OR ratios \u0026gt;1 are considered as a positive association. R\u003Csup\u003E2\u003C\/sup\u003E values\u0026gt;0 suggest a positive correlation. Normal distribution was tested, and a one-way ANOVA or Mann-Whitney test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-51\u0022\u003EIn most patients treated with DAAs, gene expression returned to control-like levels (11 out of 14 patients; 76%; pt 1, 5, 7-11, 13, 19-21). Only three out of 14 patients (post-hot, 21%; pt 6, 12, 22) showed increased gene expression post-treatment, resembling that of pre-hot patients (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-14\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4B\u003C\/a\u003E\u003C\/strong\u003E, \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-10\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2A\u003C\/a\u003E\u003C\/strong\u003E). Two out of these three post-hot patients showed persistent inflammation by histology (pt 12, MHAI: 2; pt22, MHAI: 4) and only one progressed to cirrhosis (Pt 22, \u003Cstrong\u003ETable 1\u003C\/strong\u003E).\u003C\/p\u003E\u003Cp id=\u0022p-52\u0022\u003EAmong patients with paired liver biopsies (16\/22) the fibrosis stage either worsened or remained similar in the pre-hot subcluster (pt 10-13, 19-22), while it consistently remained low in the pre-cold group (pt 5-8) after DAA treatment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-8-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F8\u0022\u003EFig. 8B\u003C\/a\u003E\u003C\/strong\u003E). Although patients with poor outcomes (pt 4, 10, 13-14, 17, 19-20, 22) had significantly increased MHAI scores (p\u0026lt;0.05) and fibrosis stages (p\u0026lt;0.01) compared to patients with good outcomes, there were no significant differences in ALT and viral load between the two groups (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-8-4\u0022 class=\u0022xref-fig\u0022 href=\u0022#F8\u0022\u003EFig. 8C\u003C\/a\u003E\u003C\/strong\u003E). We observed that pre-hot patients had 47 genes that were significantly (p\u0026lt;0.05) regulated (up and downregulated) compared to the pre-cold subcluster and mainly consisted of pro-inflammatory genes (\u003Cstrong\u003ETable S5\u003C\/strong\u003E). Next, we investigated whether the expression of these genes correlated with inflammatory activity (MHAI) and fibrosis stage after treatment. Thirty of these 47 genes in the pre-hot patients correlated (r = 0\u20131) with the fibrosis stage, and twenty-two genes correlated (r = 0\u20131) with the MHAI score (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-8-5\u0022 class=\u0022xref-fig\u0022 href=\u0022#F8\u0022\u003EFig. 8D\u003C\/a\u003E\u003C\/strong\u003E).\u003C\/p\u003E\u003Cp id=\u0022p-53\u0022\u003EHistologic evaluation of liver biopsies showed that 13\/17 (76.5%; pt 1-2, 4, 7-8, 10-13, 19-22) had persistent inflammation (MHAI \u0026gt; 2) after DAA treatment, and eight out of these 13 patients (61.5%) started with a pre-hot hepatic gene expression profile before treatment. Only ten (76.9%; pt 7-8, 10-13, 19-22) of these 13 patients had available paired pre- and post-gene expression data (\u003Cstrong\u003ETable 1\u003C\/strong\u003E). Six out of these 13 patients (46.2%; pt 4, 10, 13,19-20, 22; MHAI: 2-4\/18 and fibrosis stages; 2-6\/6) had poor clinical outcomes and five out of these six patients (83.3%: pt 10, 13, 19-20, 22) started with a pre-hot gene expression profile. Two of these 13 patients (15.4%; pt 12, 22) began with a baseline pre-hot gene signature and had a post-hot gene expression signature after treatment. However, these two patients had markedly different clinical outcomes after DAA treatment; one appeared like a control, while the other developed cirrhosis. Of note, patients 4 and 19, who had advanced fibrosis before treatment, developed HCC (\u003Cstrong\u003ETable 1\u003C\/strong\u003E). The viral load did not correlate with inflammation scores or fibrotic stages post-DAA treatment. MHAI scores pre-DAA from all patients or MHAI scores from patients with persistent inflammation were not significantly associated with outcomes (Fisher test, p:0.182 and p:0.237, respectively) (data not shown). In addition, six post-cold patients (pt 10-11, 13, 19-21) had a pre-hot signature before DAA therapy. Three of these patients had cirrhosis (pt 13, 19, 20), and two succumbed to cholangiocarcinoma and HCC, respectively (Pt 10,19, \u003Cstrong\u003ETable 1\u003C\/strong\u003E). The fibrosis stage alone was unable to predict which patients were more likely to develop a poor prognosis after DAA, as 12 out of 22 (54.5%) patients had a fibrosis stage of 3 or more before treatment, and of those 12, only six (50.0%; Pt 13-14,17,19-20, and 22) developed cirrhosis, cancer and chronic liver-related death (\u003Cstrong\u003ETable 1\u003C\/strong\u003E). Patient 20 was the only one who experienced substantial fibrosis progression from stage 1 before treatment to stage 5 after DAA.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-19\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EDiscussion\u003C\/h2\u003E\u003Cp id=\u0022p-54\u0022\u003EHCV is now a curable disease for most individuals\u003Csup\u003E\u003Ca id=\u0022xref-ref-2-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-2\u0022\u003E2\u003C\/a\u003E\u003C\/sup\u003E. However, despite the successful elimination of the virus, patients are still at risk of liver-related complications, especially if they already have pre-existing liver damage, such as advanced fibrosis \u003Csup\u003E\u003Ca id=\u0022xref-ref-25-7\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E\u003C\/sup\u003E. We and others \u003Csup\u003E\u003Ca id=\u0022xref-ref-23-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-23\u0022\u003E23\u003C\/a\u003E\u2013\u003Ca id=\u0022xref-ref-25-8\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E\u003C\/sup\u003E have observed that many patients have persistent lymphocytic portal tract inflammation after treatment, and we questioned whether this had any clinical significance. It is well known that macrophages and T cells play essential roles in the protective response to HCV, and chronic infection impairs effective macrophage activation and induces T cell dysfunction \u003Csup\u003E\u003Ca id=\u0022xref-ref-15-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-15\u0022\u003E15\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-45-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-45\u0022\u003E45\u003C\/a\u003E\u2013\u003Ca id=\u0022xref-ref-47-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-47\u0022\u003E47\u003C\/a\u003E\u003C\/sup\u003E. Host factors, including male sex, aging, and alcohol consumption, have been shown to have a stronger association with fibrosis progression in chronic HCV than inflammatory activity or virological factors \u003Csup\u003E\u003Ca id=\u0022xref-ref-48-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-48\u0022\u003E48\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-49-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-49\u0022\u003E49\u003C\/a\u003E\u003C\/sup\u003E. However, relatively little is known about what happens to the gene signatures or macrophage phenotypes of these immune cells in the liver after DAA. We analyzed liver biopsies from patients before and after treatment to determine if the hepatic microenvironment had residual gene and protein expression changes after the virus was successfully treated. We compared these to liver biopsies from uninfected controls. We analyzed gene expression and characterized intrahepatic immune cells \u003Cem\u003Ein situ\u003C\/em\u003E using spatial analysis, a technique that preserves the liver architecture \u003Csup\u003E\u003Ca id=\u0022xref-ref-50-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-50\u0022\u003E50\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-55\u0022\u003EAll patients with chronic HCV in this cohort achieved SVR and had normal transaminases and reduced inflammatory activity (by MHAI) after treatment (\u003Cstrong\u003ETable 1\u003C\/strong\u003E, \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-1-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFig. 1\u003C\/a\u003E)\u003C\/strong\u003E. However, unlike other studies, we did not observe a significant reduction in fibrosis after achieving SVR (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-1-7\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFig. 1\u003C\/a\u003E)\u003C\/strong\u003E\u003Csup\u003E\u003Ca id=\u0022xref-ref-51-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-51\u0022\u003E51\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-52-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-52\u0022\u003E52\u003C\/a\u003E\u003C\/sup\u003E. In most patients, the elimination of HCV decreased interferon-mediated inflammatory and antiviral responses to levels like uninfected controls (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-11\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2\u003C\/a\u003E, Fig. S3D\u003C\/strong\u003E). DAA therapy is known to downregulate genes associated with antiviral responses and interferon-stimulated genes (ISGs) in different myeloid and lymphoid cell subsets in the liver \u003Csup\u003E\u003Ca id=\u0022xref-ref-37-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-37\u0022\u003E37\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-39-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-39\u0022\u003E39\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-53-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-53\u0022\u003E53\u003C\/a\u003E\u2013\u003Ca id=\u0022xref-ref-55-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-55\u0022\u003E55\u003C\/a\u003E\u003C\/sup\u003E. Kupffer cells have also been shown to be the primary cellular source of hepatic IL-1\u03b2 during HCV infection \u003Csup\u003E\u003Ca id=\u0022xref-ref-56-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-56\u0022\u003E56\u003C\/a\u003E\u003C\/sup\u003E. Studies have shown that this normalization cannot be achieved in patients treated with IFN-based therapies\u003Csup\u003E\u003Ca id=\u0022xref-ref-57-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-57\u0022\u003E57\u003C\/a\u003E\u003C\/sup\u003E. Correlating with the observed decrease in gene expression of several inflammatory mediators after DAA, macrophages in the liver showed a significant shift from pro-inflammatory (M1-like) to anti-inflammatory (M2-like) phenotypes at the gene and protein level (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-7\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3\u003C\/a\u003E, \u003Ca id=\u0022xref-fig-6-8\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003E6\u003C\/a\u003E\u003C\/strong\u003E). HCV induced an inflammatory response marked by the upregulation of pro-inflammatory M1 macrophage activation (CD80, CCL5, CXCL9), which decreased post-treatment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-8\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3B\u003C\/a\u003E, Fig. S1A\u003C\/strong\u003E). Overall gene expression of CD14 and CD16 decreased during infection and post-treatment. In contrast, the expression of CD68 and CD163 remained stable (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-9\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3C\u003C\/a\u003E\u003C\/strong\u003E). A similar analysis of chronic HCV-infected human livers post-DAA treatment showed similar results for CD68 \u003Csup\u003E\u003Ca id=\u0022xref-ref-52-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-52\u0022\u003E52\u003C\/a\u003E\u003C\/sup\u003E. Recently, it was demonstrated that the presence of different myeloid subpopulations in the liver, including several CD14+ and CD16+ subsets, were differentially up- or down-regulated post-DAA treatment and contributed to the whole pool of ISG and MHC-II genes expressed during HCV infection \u003Csup\u003E\u003Ca id=\u0022xref-ref-55-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-55\u0022\u003E55\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-56\u0022\u003EThe lack of significant changes in the gene expression of CD14, CD16, CD68, and CD163 pre-vs. post-treatment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-10\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3C\u003C\/a\u003E\u003C\/strong\u003E) may be explained by the differential up\/down-regulation of specific subsets post-treatment \u003Csup\u003E\u003Ca id=\u0022xref-ref-55-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-55\u0022\u003E55\u003C\/a\u003E\u003C\/sup\u003E. Alternatively, nCounter gene expression analysis was conducted on homogenized liver tissue, which may have diluted the detection of specific cell types. Due to the latter possibility, we moved to spatial imaging to further characterize macrophage changes before and after DAA. With this approach that preserves the liver architecture, we detected an overall shift in pro-inflammatory (i.e., CD14+ macrophage populations) to anti-inflammatory (i.e., CD16+ macrophage populations) cell phenotypes (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-6-9\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFig. 6G-I\u003C\/a\u003E\u003C\/strong\u003E). Chronic HCV infection causes constant inflammatory cytokine production by macrophages, so it makes sense that the elimination of the virus would significantly decrease the proportion of these phenotypes in the liver \u003Csup\u003E\u003Ca id=\u0022xref-ref-56-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-56\u0022\u003E56\u003C\/a\u003E\u003C\/sup\u003E. CD16+ phenotypes predominated after treatment and were often at considerably higher proportions than controls (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-6-10\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFig. 6I\u003C\/a\u003E\u003C\/strong\u003E). These observations align with another study that showed that the central CD16+ subpopulation increased following DAA therapy \u003Csup\u003E\u003Ca id=\u0022xref-ref-55-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-55\u0022\u003E55\u003C\/a\u003E\u003C\/sup\u003E. Unlike the gene expression results, spatial imaging detected a significant decrease in the M2-like CD14+\/CD163+ macrophage phenotype and an increase in the anti-inflammatory\/wound-healing CD16+\/CD163+ macrophage phenotype after treatment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-6-11\u0022 class=\u0022xref-fig\u0022 href=\u0022#F6\u0022\u003EFig. 6 G-I\u003C\/a\u003E\u003C\/strong\u003E).\u003C\/p\u003E\u003Cp id=\u0022p-57\u0022\u003EA closer look at the heat map shown in \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-12\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFigure 2\u003C\/a\u003E\u003C\/strong\u003E identified an apparent separation of patients in both the pre- and post-treatment groups with high or low gene expression levels compared to the other patients. Further analysis revealed two distinct inflammatory patterns before treatment. The first pattern (pre-hot) had high expression of genes related to pro-inflammatory (NLRP3, TLR2-4, NFkB, Jak2-3\/STAT1-2, TNF) and antiviral (ISG15\/20, MX1, OAS3) responses, type I\/III IFNs ( IFITM1-2, IFNAR1-2, IRF1,4, IFNL1-2), and MHC-I\/II antigen presentation (HLA-C, TAP1-2, HLA-DMA, HLA-DRA). The second pattern (pre-cold) included a similar interferon and antiviral gene profile with a smaller number of genes (ISG15\/20, IFI27, MX1, HLA-A\/B, STAT2) and lower overall gene expression (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-2-13\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFig. 2\u003C\/a\u003E, \u003Ca id=\u0022xref-fig-4-15\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003E4\u003C\/a\u003E; Tables S5-7\u003C\/strong\u003E). Although we did not evaluate host genetic variations in this cohort of patients, it is well known that variants of type III IFNs (IFN-\u03bb3\/4 gene) influence differential levels of ISG expression, HCV pathogenesis, and response to IFN\u03b1 and DAAs treatment \u003Csup\u003E\u003Ca id=\u0022xref-ref-58-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-58\u0022\u003E58\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-59-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-59\u0022\u003E59\u003C\/a\u003E\u003C\/sup\u003E. Interestingly, by gene expression after achieving SVR, only three patients (post-hot, pt 6, 12, and 22) showed sustained expression of type I IFNs (IFNAR1\/2, IRF4), strong expression of type III IFNs (IFNL1-2), and the upregulation of genes and pathways associated with a mixed pro-inflammatory and anti-inflammatory\/profibrotic activity (i.e., TLRs, NFkB, TNF, TGF\u03b2, IL4\/IL13, IL10) (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-16\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4B-C\u003C\/a\u003E\u003C\/strong\u003E; \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-5-2\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003EFig. 5\u003C\/a\u003E\u003C\/strong\u003E).\u003C\/p\u003E\u003Cp id=\u0022p-58\u0022\u003ERestoration of specific T cells, including cytotoxic and exhausted CD8 T cells, has been observed by isolating these cells from patients\u2019 blood after DAA treatment \u003Csup\u003E\u003Ca id=\u0022xref-ref-22-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-60-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-60\u0022\u003E60\u003C\/a\u003E\u003C\/sup\u003E. In contrast, other systemic T cell populations, like mucosal-associated invariant T (MAIT), are known to remain dysfunctional after DAAs \u003Csup\u003E\u003Ca id=\u0022xref-ref-61-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-61\u0022\u003E61\u003C\/a\u003E\u003C\/sup\u003E. Due to these observations and the uncharacterized, persistent portal lymphocytic inflammation after DAA treatment in some patients \u003Csup\u003E\u003Ca id=\u0022xref-ref-23-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-23\u0022\u003E23\u003C\/a\u003E\u2013\u003Ca id=\u0022xref-ref-25-9\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-44-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-44\u0022\u003E44\u003C\/a\u003E\u003C\/sup\u003E, we analyzed differences in T cell-related genes before and after treatment. In the liver, we observed reduced gene expression of CD4 with chronic HCV infection that did not significantly increase after DAA treatment. This was expected since chronic HCV infection can lead to clonal exhaustion and deletion of HCV-specific CD4 T cells (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-11\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3D\u003C\/a\u003E\u003C\/strong\u003E). Another possible cause for this observation is that several patients were coinfected with HIV \u003Csup\u003E\u003Ca id=\u0022xref-ref-62-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-62\u0022\u003E62\u003C\/a\u003E\u2013\u003Ca id=\u0022xref-ref-64-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-64\u0022\u003E64\u003C\/a\u003E\u003C\/sup\u003E. However, there was no significant difference in CD4 gene expression between patients who were and were not coinfected with HIV before and after treatment (\u003Cstrong\u003EFig. S6 and Table S12\u003C\/strong\u003E). Additionally, all patients were on HAART therapy and had similar absolute T cell counts before and after treatment. A comparison of the co-infected patients pre- and post-treatment revealed no significant differences in gene expression (\u003Cstrong\u003EFig. S7\u003C\/strong\u003E). As expected, CD8A expression in the liver increased with chronic HCV infection and trended down after treatment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-12\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3D\u003C\/a\u003E\u003C\/strong\u003E). However, marked individual patient heterogeneity in Log2 levels prevented statistically significant differences from being detected when comparing the pre- and post-treatment groups. \u003Csup\u003E\u003Ca id=\u0022xref-ref-65-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-65\u0022\u003E65\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-66-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-66\u0022\u003E66\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-59\u0022\u003EDue to the observed heterogeneity in T cell phenotypes in the liver at the gene level, we used multispectral imaging to more clearly compare differences in patients before and after DAA (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-7-7\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7A\u003C\/a\u003E\u003C\/strong\u003E). Similar to the gene expression results, CD8+ T cells (CD3+CD8+) increased with HCV and persisted in some patients after DAA (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-13\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3D\u003C\/a\u003E\u003C\/strong\u003E, \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-7-8\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7A\u003C\/a\u003E\u003C\/strong\u003E). CD4+ T cell phenotypes became slightly more prevalent after DAA treatment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-14\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFig. 3D\u003C\/a\u003E\u003C\/strong\u003E, \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-7-9\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7A\u003C\/a\u003E\u003C\/strong\u003E). Persistent portal tract inflammation was observed in 76.5% of the study patients after DAA and all of patients had normal transaminases after SVR (\u003Cstrong\u003E\u003Ca id=\u0022xref-table-wrap-1-2\u0022 class=\u0022xref-table\u0022 href=\u0022#T1\u0022\u003ETable S1\u003C\/a\u003E\u003C\/strong\u003E). Some studies have reported that about 10% of the patients with ongoing inflammation will still have mildly abnormal liver enzymes after treatment \u003Csup\u003E\u003Ca id=\u0022xref-ref-44-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-44\u0022\u003E44\u003C\/a\u003E\u003C\/sup\u003E. As observed in \u003Cstrong\u003E\u003Ca id=\u0022xref-fig-3-15\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFigures 3\u003C\/a\u003E and \u003Ca id=\u0022xref-fig-7-10\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003E7\u003C\/a\u003E\u003C\/strong\u003E, in both the gene and protein levels, patients had marked heterogeneity in the proportions of various T cell phenotypes. This again caused a lack of significance when comparing these cells between the different patient groups (data not shown). Memory T cells (i.e., phenotypes containing CD45RO) were responsible for much of this variability. They persisted after antiviral therapy (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-7-11\u0022 class=\u0022xref-fig\u0022 href=\u0022#F7\u0022\u003EFig. 7\u003C\/a\u003E\u003C\/strong\u003E). These phenotypes were more prevalent in patients with persistent inflammation following SVR (i.e., Pt 1, 8, 12, and 13).\u003C\/p\u003E\u003Cp id=\u0022p-60\u0022\u003EMemory T cells have been shown to inhibit NLRP3 inflammasome activation \u003Csup\u003E\u003Ca id=\u0022xref-ref-67-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-67\u0022\u003E67\u003C\/a\u003E\u003C\/sup\u003E, which was upregulated in the pre-hot subpopulation pre-DAA (\u003Cstrong\u003ETable S6\u003C\/strong\u003E). Interestingly, we previously demonstrated that CD3+CD45RO+ memory T cells had a stronger correlation with fibrosis progression in patients with metabolic dysfunction associated steatotic liver disease (MASLD\/MASH) \u003Csup\u003E\u003Ca id=\u0022xref-ref-68-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-68\u0022\u003E68\u003C\/a\u003E\u003C\/sup\u003E. We also compared individual variations in T cell phenotypes infiltrating the liver microenvironment of controls and patients pre- and post-DAA treatment with and without persistent inflammation (\u003Cstrong\u003EFig. S5A-B)\u003C\/strong\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-61\u0022\u003ENext, we compared patient laboratory data, histopathologic features, gene expression, and spectral imaging results to determine if any were correlated with disease progression. Patients with poor clinical outcomes had significantly higher inflammatory activity scores and fibrosis stages before DAA (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-8-6\u0022 class=\u0022xref-fig\u0022 href=\u0022#F8\u0022\u003EFig. 8C\u003C\/a\u003E\u003C\/strong\u003E). Six patients had advanced fibrosis\/cirrhosis (27.2%; pt 13-14,17, 19-20, and 22). Two patients with cirrhosis died from ESLD (pts 14 and 20). Out of the 22 patients, three developed cancer and succumbed to the disease (13.6%; pt 4: HCC, pt 10: CCa, and t 19: HCC). However, studies have shown that patients with HCV-related HCC who obtain SVR achieve a 60% - 70% lower risk of 5-year all-cause and liver-related mortality\u003Csup\u003E\u003Ca id=\u0022xref-ref-69-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-69\u0022\u003E69\u003C\/a\u003E\u003C\/sup\u003E. Interestingly, differentially expressed genes in the pre-hot versus the pre-cold patients showed increased expression of genes associated with liver cancer progression (CXCR4, BCL2, FYN), like other studies \u003Csup\u003E\u003Ca id=\u0022xref-ref-40-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-40\u0022\u003E40\u003C\/a\u003E\u2013\u003Ca id=\u0022xref-ref-42-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-42\u0022\u003E42\u003C\/a\u003E\u003C\/sup\u003E. A comparison of the overexpressed genes (including JAK2, IRF7, BCL2, IKBKE, CXCR4) in the pre-hot subcluster (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-17\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4A\u003C\/a\u003E\u003C\/strong\u003E) when compared to the pre-cold subcluster (\u003Cstrong\u003ETable S5\u003C\/strong\u003E) had a positive correlation with inflammatory activity scores and fibrosis stages post-DAA treatment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-8-7\u0022 class=\u0022xref-fig\u0022 href=\u0022#F8\u0022\u003EFig. 8D\u003C\/a\u003E and Table 1\u003C\/strong\u003E). Patients with high gene expression (66.7%, pre-hot) more often had poor clinical outcomes and more advanced liver disease with higher fibrosis stages and inflammatory activity after treatment (\u003Cstrong\u003E\u003Ca id=\u0022xref-fig-4-18\u0022 class=\u0022xref-fig\u0022 href=\u0022#F4\u0022\u003EFig. 4\u003C\/a\u003E-\u003Ca id=\u0022xref-fig-5-3\u0022 class=\u0022xref-fig\u0022 href=\u0022#F5\u0022\u003E5\u003C\/a\u003E, \u003Ca id=\u0022xref-fig-8-8\u0022 class=\u0022xref-fig\u0022 href=\u0022#F8\u0022\u003EFig. 8\u003C\/a\u003E\u003C\/strong\u003E). Viral load did not correlate with inflammatory activity scores or fibrotic stages after DAA treatment (data not shown) \u003Csup\u003E\u003Ca id=\u0022xref-ref-24-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-24\u0022\u003E24\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-44-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-44\u0022\u003E44\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-62\u0022\u003EA significant strength of this study was the use of liver biopsies obtained both before and after DAA treatment. This allowed us to evaluate histopathologic features, gene and protein expression changes, and individual responses to HCV infection in 22 patients who achieved SVR. Post-treatment liver biopsies are exceedingly rare, allowing us to evaluate the shift in the hepatic microenvironment with and without the virus. We correlated gene and protein signatures with clinical and disease progression, providing valuable insights into the consequences of viral clearance and changes in the immune response after DAA therapy. Unfortunately, some of the paired liver biopsies did not have enough tissue for histology, RNA extraction, and the two spectral imaging panels to be conducted on the same patients. This decreased the sample size of several experiments.\u003C\/p\u003E\u003Cp id=\u0022p-63\u0022\u003EThe gene expression analysis identified distinct pre-treatment inflammatory profiles characterized by high (pre-hot) or low (pre-cold) expression of ISGs and antiviral responses. Notably, the pre-hot pattern correlated with adverse outcomes (cirrhosis progression, HCC, and liver failure-related mortality), highlighting the potential for these patterns to serve as prognostic markers. Despite initial variability in gene expression, MHAI scores, and fibrosis stages, DAA treatment effectively controlled viral infection, deactivated antiviral pathways, and returned inflammation to baseline levels in most patients. This study is one of the first to report heterogeneous macrophage subsets in liver biopsies using multiplex immunofluorescence, confirming recent single-cell results that show dynamic and specific gene expression changes in some of these populations post-DAA treatment, underscoring the importance of studies of liver tissue when compared to blood samples. Most persistent inflammation observed in liver biopsies post-treatment appears to be memory T cells. Integrating gene expression profiles with clinical data could enhance risk stratification for patients at risk of poor outcomes, thereby identifying individuals who could benefit from more intensive monitoring and lifestyle modifications to prevent further liver disease progression.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section data-availability\u0022 id=\u0022sec-21\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EData Availability\u003C\/h2\u003E\u003Cp id=\u0022p-64\u0022\u003EAll data pertinent to this study are either included within the main article or provided as supplementary materials.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-22\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EList of abbreviations\u003C\/h2\u003E\u003Cdiv class=\u0022section glossary\u0022\u003E\u003Cdl id=\u0022def-list-1\u0022\u003E\u003Cdt id=\u0022def-item-1\u0022\u003EHCV\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Ehepatitis C virus\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-2\u0022\u003EDAA\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Edirect-acting antiviral\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-3\u0022\u003ESVR\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Esustained virologic response\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-4\u0022\u003EPOST\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Epost-daa treatment\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-5\u0022\u003EPRE\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Epre-daa treatment\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-6\u0022\u003EHCC\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Ehepatocellular carcinoma\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-7\u0022\u003EIFN\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Einterferon\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-8\u0022\u003EHIV\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Ehuman immunodeficiency virus\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-9\u0022\u003EUTMB\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Euniversity of Texas medical branch\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-10\u0022\u003EIRB\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Einstitutional review board\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-11\u0022\u003ECAP\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Ecollege of American pathologist\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-12\u0022\u003EMHAI\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Emodified hepatitis activity index\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-13\u0022\u003EALT\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Ealanine aminotransferase\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-14\u0022\u003EAST\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Easpartate aminotransferase\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-15\u0022\u003EALP\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Ealkaline phosphatase\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-16\u0022\u003ECLIA\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Eclinical laboratory improvement amendments\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-17\u0022\u003EFFPE\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Eformalin-fixed, paraffin-embedded\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-18\u0022\u003ERNA\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Eribonucleic acid\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-19\u0022\u003ERCC\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Eresource compiler files\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-20\u0022\u003EPCA\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Eprincipal component analysis\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-21\u0022\u003EDEG\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Edifferentially expressed genes\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-22\u0022\u003EROIs\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Eregions of interest\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-23\u0022\u003EANOVA\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Eanalysis of variance\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-24\u0022\u003EDAPI\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003E4\u2032,6-diamidino-2-phenylindole\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-25\u0022\u003EJAK\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Ejanus kinase\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-26\u0022\u003ESTAT\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Esignal transducer and activation of transcription\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-27\u0022\u003EBMI\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Ebody mass index\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-28\u0022\u003ETNF\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Etumor necrosis factor\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-29\u0022\u003ETGFB\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Etransforming growth factor beta\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-30\u0022\u003EMHC\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Emajor histocompatibility complex\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-31\u0022\u003ENKC\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Enatural killer cells\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-32\u0022\u003EISG\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Einterferon-stimulated genes\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-33\u0022\u003EIFI\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Einterferon inducible protein\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-34\u0022\u003EMX\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Emixovirus resistance\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-35\u0022\u003ETIFF\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Etagged image file format\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-36\u0022\u003EH\u0026amp;E\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Ehematoxylin and eosin\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-37\u0022\u003ETSNE\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Et-distributed stochastic neighbor embedding\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-38\u0022\u003EMAIT\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Emucosal-associated invariant T cells\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-39\u0022\u003EHAART\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Ehighly active antiretroviral therapy\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-40\u0022\u003ENLRP\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Enucleotide-binding domain, leucine-rich-containing family, pyrin domain containing\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-41\u0022\u003EMASLD\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Emetabolic dysfunction-associated steatotic liver disease\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-42\u0022\u003EMASH\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Emetabolic dysfunction-associated steatohepatitis\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-43\u0022\u003EESLD\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Eend-stage liver disease\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-44\u0022\u003EPT\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Eprothrombin time\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-45\u0022\u003EINR\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Einternational normalized ratio\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-46\u0022\u003EBY\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003EBenjamini-Yekutieli\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-47\u0022\u003ESTRING\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Esearch tool for the retrieval of interacting genes\/proteins\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-48\u0022\u003EFDR\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Efalse discovery rates\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-49\u0022\u003EMCL\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003EMarkov cluster algorithm\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-50\u0022\u003Ept\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Epatient\u003Cspan class=\u0022def-item-dd-sep\u0022\u003E\u003C\/span\u003E\u003C\/dd\u003E\u003Cdt id=\u0022def-item-51\u0022\u003EAI\u003Cspan class=\u0022def-item-dt-sep\u0022\u003E\u003C\/span\u003E\u003C\/dt\u003E\u003Cdd\u003Eartificial intelligence\u003C\/dd\u003E\u003C\/dl\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-23\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EConflict of interest\u003C\/h2\u003E\u003Cp id=\u0022p-116\u0022\u003EHSL and OAS have a filed patent titled \u201cSystems and methods for spectral imaging characterization of macrophages for use in personalization of targeted therapies to prevent fibrosis development in patients with chronic liver disease.\u201d (Board of Regents, The University of Texas System, United States, Galveston, Texas; Pub. No: US 20210293814.) A.R. serves as a member of Voxel Analytics LLC and consults for Tempus Labs Inc. and Tata Consultancy Services Ltd. The remaining authors who have taken part in this study declared that they have nothing to disclose regarding funding or conflict of interest concerning this manuscript.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-24\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EFinancial support\u003C\/h2\u003E\u003Cp id=\u0022p-117\u0022\u003EThe authors gratefully acknowledge the financial support provided by their grant funding sources. O.A.S., E.A., S.K. H.S., L.B., A.R., and H.L.S. were partially supported by an R01 from NIDDK (1R01DK125730-01A1-4). O.A.S. and H.S.L. were additionally supported by a Moody Endowment Grant (2014-07; LIME 19016). Preliminary optimization studies were partly supported by the National Center for Advancing Translational Science Clinical and Translational Science Awards Grant NCATS CTSA Grant KL2 Scholars Program (KL2TR001441-06). The acquisition of the Vectra 3 microscope was made possible through funding from the UT Systems Faculty Science and Technology Acquisition and Retention (STARs) Program. A.R. and S.K. were supported by CCSG Bioinformatics Shared Resource 5 P30 CA046592, a gift from Agilent Technologies, and a Precision Health Investigator award from U-M Precision Health. The NCI Grant R37-CA214955 partially supported S.K. and A.R. S.K. and A.R. were also partially supported by The University of Michigan (U-M) startup institutional research funds. S.K. and A.R. were also supported by a Research Scholar Grant from the American Cancer Society (RSG-16-005-01).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-25\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAuthor contributions\u003C\/h2\u003E\u003Cp id=\u0022p-119\u0022\u003EData curation: DEM, EA, OAS, JZ. Formal analysis: DEM, EA, OAS, TGW, SK, AR, HS. Methodology: DEM, EA, OAS. Software: TGW, DB, SK, AR. Validation: EA, OAS. Resources: MF. Project administration, Conceptualization, Supervision: HLS. Writing \u2013 original draft: OAS, DEM. Writing \u2013 review \u0026amp; editing: DEM, HLS, OAS. Reviewed the manuscript: all authors.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-26\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EData availability statement\u003C\/h2\u003E\u003Cp id=\u0022p-120\u0022\u003EAll data relevant to the study are included in the article or supplementary material.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-27\u0022\u003E\u003Ch2 class=\u0022\u0022\u003ESupplementary Figure Legends\u003C\/h2\u003E\u003Cp id=\u0022p-121\u0022\u003E\u003Cstrong\u003ESupplementary Figure 1.\u003C\/strong\u003E Genes included in the PanCancer panel, utilized by the CIBERSORT tool to estimate the abundance of macrophages, T cells, and NK cell populations, were analyzed: (\u003Cstrong\u003EA\u003C\/strong\u003E) before and after DAA treatment and (\u003Cstrong\u003EB\u003C\/strong\u003E) within pre- and post-treatment subclusters.\u003C\/p\u003E\u003Cp id=\u0022p-122\u0022\u003E\u003Cstrong\u003ESupplementary Figure 2. Comparison of clinical data from patients pre- and post-DAA treatment subclustered by gene expression patterns.\u003C\/strong\u003E We compared the clinical and laboratory data in patients pre- and post-DAA therapy with two distinct patterns of gene expression and clustering: Pre-hot (high gene expression profile pre-DAA therapy compared to controls), pre-cold (low gene expression profile pre-DAA therapy compared to controls), post-hot (high gene expression post-DAA therapy comparable to pre-hot), and post-cold (low gene expression post-DAA therapy comparable to controls). The pre-hot subcluster showed an increased MHAI score and ALT, which decreased post-DAA treatment. Liver biopsies were graded for inflammatory activity using the MHAI scoring criteria (0-18) and staged for fibrosis using Ishak (1-6) criteria\u003Csup\u003E\u003Ca id=\u0022xref-ref-30-4\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-30\u0022\u003E30\u003C\/a\u003E\u003C\/sup\u003E. Normal distribution was tested, and an unpaired t-test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001. Abbreviations: Pre, (pre-DAA treatment); Post, (post-DAA treatment); MHAI, modified hepatic activity index; ALT, Alanine transaminase; AST, Aspartate aminotransferase; ALP, Alkaline phosphatase; FFPE, Formalin-fixed paraffin-embedded; PT, Prothrombin time; INR, International Normalized Ratio.\u003C\/p\u003E\u003Cp id=\u0022p-123\u0022\u003E\u003Cstrong\u003ESupplementary Figure 3.\u003C\/strong\u003E Differentially expressed genes from patients pre- and post-DAA treatment. The volcano plots were constructed using fold-change values and adjustable (BY) p-values. The vertical lines correspond to 0.6-fold changes up and down, and the solid and dashed horizontal lines represent an adjustable (BY) p-value \u0026lt;0.01 or \u0026lt;0.05, respectively. The red dots in the plot represent the differentially expressed mRNAs with statistical significance. Abbreviations: Ctrls, controls; Pre-hot (high gene expression profile pre-DAA therapy), pre-cold (low gene expression profile pre-DAA therapy), post-hot (high gene expression post-DAA therapy), and post-cold (low gene expression post-DAA therapy).\u003C\/p\u003E\u003Cp id=\u0022p-124\u0022\u003E\u003Cstrong\u003ESupplementary Figure 4.\u003C\/strong\u003E The Venn diagram illustrates genes significantly expressed across the pre- and post-DAA therapy subcluster groups compared to the control group. Differentially expressed genes with an adjusted (BY) p-value \u0026lt; 0.01 and a log2-fold change \u2265 0.6 were selected to create the Venn diagram. The post-cold subcluster group was not included because no genes were significantly expressed compared to the control. Genes in red and blue represent those up-regulated or down-regulated, respectively. Abbreviations: Pre-hot (high gene expression profile pre-DAA therapy), pre-cold (low gene expression profile pre-DAA therapy), post-hot (high gene expression post-DAA therapy).\u003C\/p\u003E\u003Cp id=\u0022p-125\u0022\u003E\u003Cstrong\u003ESupplementary Figure 5. T cell protein expression patterns pre and post-DAA treatment. (A)\u003C\/strong\u003E Unstained slides were stained with a multiplex T cell panel (CD3+, CD4+, CD8+, CD45RO+, FoxP3+, and DAPI). The Multicomponent TIFF images were then analyzed with Visiopharm to determine the type and number of T cell phenotypes in the portal tracts. The data were used to construct t-SNE plots for individual controls and patients pre- and post-DAA therapy with or without persistent inflammation. Each colored dot represents a unique cellular phenotype, and gray dots represent negative cells for all the markers evaluated. (\u003Cstrong\u003EB\u003C\/strong\u003E) These images represent the phenotypic distribution in the portal tract of the multiplex T cell panel (CD3+, CD4+, CD8+, CD45RO+, FoxP3+, and DAPI) from controls and patients pre-DAA, and post-DAA therapy, with or without persistent inflammation. Each colored dot represents a unique cellular phenotype, and gray dots represent negative cells for all the markers evaluated. Abbreviations: Pre-,pre-DAA therapy; Post-,post-DAA therapy; PI, persistent inflammation; NPI, not persistent inflammation.\u003C\/p\u003E\u003Cp id=\u0022p-126\u0022\u003E\u003Cstrong\u003ESupplementary Figure 6. Box plots comparing the gene expression of CD4, CD8, FoxP3 before and after treatment with DAA\u003C\/strong\u003E. There was no significant difference in CD4, CD8, and FoxP3 gene expression between patients who were and were not coinfected with HIV before and after treatment. Normal distribution was tested, and an unpaired t-test was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001. Abbreviations: Ctrl, (controls); Pre-HIV, (Patient with HIV and pre-DAA treatment); Pre-HIV-neg, (Patient without HIV and pre-DAA treatment); Post-HIV, (Patient with HIV and post-DAA treatment); Post-HIV-neg, (Patient without HIV and post-DAA treatment).\u003C\/p\u003E\u003Cp id=\u0022p-127\u0022\u003E\u003Cstrong\u003ESupplementary Figure 7. Gene expression patterns in patients with HCV are not significantly affected by their HIV status.\u003C\/strong\u003E To determine whether HIV co-infection was a confounding factor in the observed gene expression differences before and after treatment, we conducted a PCA (\u003Cstrong\u003EA, B\u003C\/strong\u003E) and a Fisher\u2019s exact test analysis (\u003Cstrong\u003EC, D\u003C\/strong\u003E) in groups of patients with HCV pre-(\u003Cstrong\u003EA, C;\u003C\/strong\u003E pre-hot, n = 9; pre-cold, n = 8) and post-(\u003Cstrong\u003EB, D;\u003C\/strong\u003E post-hot, n = 3; post-cold, n = 11) treatment compared to HIV status (+\/-). Patients co-infected with HIV exhibited overlapping clustering with non-co-infected patients pre-(\u003Cstrong\u003EA)\u003C\/strong\u003E and post-(\u003Cstrong\u003EB\u003C\/strong\u003E) treatment, and the clustering was influenced by cold or hot status both before and after treatment, as previously demonstrated. Gene expression patterns in patients with HCV pre-(\u003Cstrong\u003EC\u003C\/strong\u003E) and post-(\u003Cstrong\u003ED\u003C\/strong\u003E) treatment were not significantly influenced by HIV status (Fisher\u2019s test, p \u0026gt; 0.05).\u003C\/p\u003E\u003Cdiv id=\u0022T1\u0022 class=\u0022table pos-float\u0022\u003E\u003Cdiv class=\u0022table-inline table-callout-links\u0022\u003E\u003Cdiv class=\u0022callout\u0022\u003E\u003Cspan\u003EView this table:\u003C\/span\u003E\u003Cul class=\u0022callout-links\u0022\u003E\u003Cli class=\u0022view-inline first\u0022\u003E\u003Ca href=\u0022\u0022 class=\u0022table-expand-inline\u0022 data-table-url=\u0022\/highwire\/markup\/948008\/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0026amp;table-expand-inline=1\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView inline\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022view-popup\u0022\u003E\u003Ca href=\u0022\/highwire\/markup\/948008\/expansion?width=1000\u0026amp;height=500\u0026amp;iframe=true\u0026amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0022 class=\u0022colorbox colorbox-load table-expand-popup\u0022 rel=\u0022gallery-fragment-tables\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView popup\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022download-ppt last\u0022\u003E\u003Ca href=\u0022\/highwire\/powerpoint\/948008\u0022 class=\u0022highwire-figure-link highwire-figure-link-ppt\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload powerpoint\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022table-caption\u0022\u003E\u003Cspan class=\u0022table-label\u0022\u003ETable S1.\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EStudy Patient Set 1, 2, and 3: Demographic and laboratory data for patients with HCV pre- and post-DAA treatment analyzed with nCounter and multiplexing imaging\u003C\/span\u003E\u003Cp id=\u0022p-128\u0022 class=\u0022first-child\u0022\u003ENormal range: ALT, 9-51 U\/L; AST,13-40 U\/L; ALP, 34-122 U\/L; Albumin, 3.5-5 g\/dL; Bilirubin, 0.1-1.1 mg\/dL; Platelets,166-358 x1000\/\u00b5L; PT, 11-13.5 sec; INR, 1.1. Abbreviations: Alb., albumin; Pt #, patient number; DAA, Direct-actin antivirals; Pre, pre-treatment; Post, post-treatment; Post\u003Csup\u003E+++\u003C\/sup\u003E, patients with persistent inflammation post-DAA; F, female; M, male; ChCA, cholangiocarcinoma; HCV, hepatitis C virus; HCV gen, HCV genotype; nd, not detected; MHAI, modified hepatic activity index (0-18); No rec.labs, No recent labs; ALT, Alanine transaminase; AST, Aspartate aminotransferase; ALP, Alkaline phosphatase; Plt, Platelets; PT, Prothrombin time; INR, International Normalized Ratio; Tot. bil., total bilirubin; MAC, macrophage. Outcomes: HCC, Hepatocellular carcinoma; n\/a, no tissue available; Asterisk on top of MHAI, ALT, and AST represent significant statistical differences between the groups. A normal distribution was tested and an unpaired t-test or a Mann-Whitney (MW) test, as appropriate, with Holm-Sidak correction was used to compare the differences between the groups. *p \u0026lt; 0.05; **p \u0026lt; 0.01; ***p \u0026lt; 0.001; ****p \u0026lt; 0.0001. Superscript a: Patient 4 and 10 succumbed to HCC and ChCA, respectively, while patients 14 and 19 die of cirrhosis-related complications. Patient 13 die of cardiogenic shock. b: All patients completed the duration of the treatment according to the guidelines at the time of treatment except patient 22 and 14. c: Patient did not receive any treatment, d: Treatment discontinue after 5 weeks due to renal complications.\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ack\u0022 id=\u0022ack-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAcknowledgments\u003C\/h2\u003E\u003Cp id=\u0022p-118\u0022\u003EWe would like to thank the UTMB Institutional Biorepository who provided research histology services in support of this study.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section fn-group\u0022 id=\u0022fn-group-1\u0022\u003E\u003Ch2\u003EFootnotes\u003C\/h2\u003E\u003Cul\u003E\u003Cli class=\u0022fn\u0022 id=\u0022fn-1\u0022\u003E\u003Cp id=\u0022p-1\u0022\u003E\u003Ca class=\u0022rev-xref\u0022 href=\u0022#xref-fn-1-1\u0022\u003E\u21b5\u003C\/a\u003E\u003Cspan class=\u0022fn-label\u0022\u003E\u253c\u003C\/span\u003E These authors shared their first co-authorship\u003C\/p\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ref-list\u0022 id=\u0022ref-list-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EReferences\u003C\/h2\u003E\u003Col class=\u0022cit-list ref-use-labels\u0022\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E1.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-1-1\u0022 title=\u0022View reference 1. in text\u0022 id=\u0022ref-1\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.1\u0022 data-doi=\u002210.1016\/S1473-3099(24)00307-4\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBurki\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EWHO\u2019s 2024 global hepatitis report\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ELancet Infect Dis\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EJun\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2024\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E24\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E6\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003Ee362\u003C\/span\u003E-\u003Cspan class=\u0022cit-lpage\u0022\u003Ee363\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/S1473-3099(24)00307-4\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DLancet%2BInfect%2BDis%26rft.volume%253D24%26rft.spage%253De362%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1473-3099%252824%252900307-4%26rft_id%253Dinfo%253Apmid%252F38795729%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/S1473-3099(24)00307-4\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=38795729\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E2.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-2-1\u0022 title=\u0022View reference 2. in text\u0022 id=\u0022ref-2\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.2\u0022 data-doi=\u002210.1016\/S2214-109X(20)30505-2\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EOru\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETrickey\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EShirali\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKanters\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EEasterbrook\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EDecentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ELancet Glob Health\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EApr\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E9\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E4\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003Ee431\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003Ee445\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/S2214-109X(20)30505-2\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DLancet%2BGlob%2BHealth%26rft.volume%253D9%26rft.spage%253D431e%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS2214-109X%252820%252930505-2%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/S2214-109X(20)30505-2\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E3.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-3-1\u0022 title=\u0022View reference 3. in text\u0022 id=\u0022ref-3\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.3\u0022 data-doi=\u002210.7326\/M17-1073\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBelperio\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EPS\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EChartier\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERoss\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EDB\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAlaigh\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EShulkin\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003ECuring Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAnn Intern Med\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EOct\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E03\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2017\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E167\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E7\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E499\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E504\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.7326\/M17-1073\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DAnn%2BIntern%2BMed%26rft.volume%253D167%26rft.spage%253D499%26rft_id%253Dinfo%253Adoi%252F10.7326%252FM17-1073%26rft_id%253Dinfo%253Apmid%252F28973196%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.7326\/M17-1073\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=28973196\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E4.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-4-1\u0022 title=\u0022View reference 4. in text\u0022 id=\u0022ref-4\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.4\u0022 data-doi=\u002210.1016\/j.cgh.2020.02.044\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMendizabal\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPi\u00f1ero\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERidruejo\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EDisease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EClin Gastroenterol Hepatol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EOct\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E18\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E11\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E2554\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E2563\u003C\/span\u003E.e3.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/j.cgh.2020.02.044\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DClin%2BGastroenterol%2BHepatol%26rft.volume%253D18%26rft.spage%253D2554%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cgh.2020.02.044%26rft_id%253Dinfo%253Apmid%252F32113892%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.cgh.2020.02.044\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=32113892\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E5.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-5-1\u0022 title=\u0022View reference 5. in text\u0022 id=\u0022ref-5\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.5\u0022 data-doi=\u002210.17998\/jlc.2022.05.24\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAhn\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EYH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELee\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHan\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EEffect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Liver Cancer\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ESep\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E22\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E125\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E135\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.17998\/jlc.2022.05.24\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BLiver%2BCancer%26rft.volume%253D22%26rft.spage%253D125%26rft_id%253Dinfo%253Adoi%252F10.17998%252Fjlc.2022.05.24%26rft_id%253Dinfo%253Apmid%252F37383412%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.17998\/jlc.2022.05.24\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=37383412\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E6.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-6-1\u0022 title=\u0022View reference 6. in text\u0022 id=\u0022ref-6\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.6\u0022 data-doi=\u002210.15585\/mmwr.mm6839a1\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKo\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJY\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHaight\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ESC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESchillie\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ESF\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBohm\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDietz\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EPM\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003ENational Trends in Hepatitis C Infection by Opioid Use Disorder Status Among Pregnant Women at Delivery Hospitalization - United States, 2000-2015\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EMMWR Morb Mortal Wkly Rep\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EOct\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E04\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2019\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E68\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E39\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E833\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E838\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.15585\/mmwr.mm6839a1\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DMMWR%2BMorb%2BMortal%2BWkly%2BRep%26rft.volume%253D68%26rft.spage%253D833%26rft_id%253Dinfo%253Adoi%252F10.15585%252Fmmwr.mm6839a1%26rft_id%253Dinfo%253Apmid%252F31581170%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.15585\/mmwr.mm6839a1\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=31581170\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E7.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-7-1\u0022 title=\u0022View reference 7. in text\u0022 id=\u0022ref-7\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.7\u0022 data-doi=\u002210.1111\/ppe.12934\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAhrens\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EKA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERossen\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ELM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBurgess\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAR\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPalmsten\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZiller\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EEC\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EMaternal hepatitis C prevalence and trends by county, US: 2016-2020\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EPaediatr Perinat Epidemiol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EFeb\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2023\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E37\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E134\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E142\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1111\/ppe.12934\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DPaediatr%2BPerinat%2BEpidemiol%26rft.volume%253D37%26rft.spage%253D134%26rft_id%253Dinfo%253Adoi%252F10.1111%252Fppe.12934%26rft_id%253Dinfo%253Apmid%252F36372984%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1111\/ppe.12934\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=36372984\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E8.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-8-1\u0022 title=\u0022View reference 8. in text\u0022 id=\u0022ref-8\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.8\u0022 data-doi=\u002210.1038\/nrgastro.2015.200\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHeymann\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETacke\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EImmunology in the liver--from homeostasis to disease\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENat Rev Gastroenterol Hepatol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EFeb\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2016\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E13\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E88\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E110\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/nrgastro.2015.200\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNat%2BRev%2BGastroenterol%2BHepatol%26rft.volume%253D13%26rft.spage%253D88%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnrgastro.2015.200%26rft_id%253Dinfo%253Apmid%252F26758786%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/nrgastro.2015.200\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=26758786\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E9.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-9-1\u0022 title=\u0022View reference 9. in text\u0022 id=\u0022ref-9\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.9\u0022 data-doi=\u002210.1038\/gene.2015.11\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ENoureddin\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERotman\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZhang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EHepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EGenes Immun\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2015\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E16\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E5\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E321\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E9\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/gene.2015.11\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DGenes%2BImmun%26rft.volume%253D16%26rft.spage%253D321%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fgene.2015.11%26rft_id%253Dinfo%253Apmid%252F26020282%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/gene.2015.11\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=26020282\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E10.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2025.02.17.25321289v1.10\u0022 data-doi=\u002210.1002\/hep.29877\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERamamurthy\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EN\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMarchi\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAnsari\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EImpact of Interferon Lambda 4 Genotype on Interferon-Stimulated Gene Expression During Direct-Acting Antiviral Therapy for Hepatitis C\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EHepatology\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ESep\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2018\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E68\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E3\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E859\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E871\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1002\/hep.29877\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DHepatology%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fhep.29877%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1002\/hep.29877\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E11.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2025.02.17.25321289v1.11\u0022 data-doi=\u002210.1016\/j.immuni.2017.09.006\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWolski\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EFoote\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EPK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EChen\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EDY\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EEarly Transcriptional Divergence Marks Virus-Specific Primary Human CD8\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EImmunity\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EOct\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E17\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2017\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E47\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E4\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E648\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E663\u003C\/span\u003E.e8.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/j.immuni.2017.09.006\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DImmunity%26rft.volume%253D47%26rft.spage%253D648%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.immuni.2017.09.006%26rft_id%253Dinfo%253Apmid%252F29045899%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.immuni.2017.09.006\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=29045899\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E12.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-12-1\u0022 title=\u0022View reference 12. in text\u0022 id=\u0022ref-12\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.12\u0022 data-doi=\u002210.1038\/nri1573\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERehermann\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ENascimbeni\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EImmunology of hepatitis B virus and hepatitis C virus infection\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENat Rev Immunol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EMar\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2005\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E5\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E3\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E215\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E29\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/nri1573\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNature%2Breviews.%2BImmunology%26rft.stitle%253DNat%2BRev%2BImmunol%26rft.aulast%253DRehermann%26rft.auinit1%253DB.%26rft.volume%253D5%26rft.issue%253D3%26rft.spage%253D215%26rft.epage%253D229%26rft.atitle%253DImmunology%2Bof%2Bhepatitis%2BB%2Bvirus%2Band%2Bhepatitis%2BC%2Bvirus%2Binfection.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnri1573%26rft_id%253Dinfo%253Apmid%252F15738952%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/nri1573\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=15738952\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000227302400012\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E13.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-13-1\u0022 title=\u0022View reference 13. in text\u0022 id=\u0022ref-13\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.13\u0022 data-doi=\u002210.5812\/hepatmon.29282\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELi\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EX\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZhou\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZhang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHo\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EW\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EHCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EHepat Mon\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EAug\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2015\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E15\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E8\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003Ee29282\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.5812\/hepatmon.29282\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DHepat%2BMon%26rft.volume%253D15%26rft.spage%253De29282%26rft_id%253Dinfo%253Adoi%252F10.5812%252Fhepatmon.29282%26rft_id%253Dinfo%253Apmid%252F26322111%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.5812\/hepatmon.29282\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=26322111\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E14.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-14-1\u0022 title=\u0022View reference 14. in text\u0022 id=\u0022ref-14\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.14\u0022 data-doi=\u002210.1128\/JVI.00010-17\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBalasiddaiah\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDavanian\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAleman\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EHepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Virol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EMay\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E01\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2017\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E91\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E9\u003C\/span\u003E)\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1128\/JVI.00010-17\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.00010-17%26rft_id%253Dinfo%253Apmid%252F28228595%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjE0OiI5MS85L2UwMDAxMC0xNyI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI1LzAyLzE4LzIwMjUuMDIuMTcuMjUzMjEyODkuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E15.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-15-1\u0022 title=\u0022View reference 15. in text\u0022 id=\u0022ref-15\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.15\u0022 data-doi=\u002210.3390\/cells8040374\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAhmed\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EIbrahim\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECooper\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKumar\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECrawley\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAM\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EChronic Hepatitis C Virus Infection Impairs M1 Macrophage Differentiation and Contributes to CD8\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ECells\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EApr\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E25\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2019\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E8\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E4\u003C\/span\u003E)\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3390\/cells8040374\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DCells%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fcells8040374%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3390\/cells8040374\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E16.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2025.02.17.25321289v1.16\u0022 data-doi=\u002210.1016\/j.jcmgh.2015.12.005\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESaha\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKodys\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESzabo\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EHepatitis C Virus-Induced Monocyte Differentiation Into Polarized M2 Macrophages Promotes Stellate Cell Activation via TGF-\u03b2\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ECell Mol Gastroenterol Hepatol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EMay\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2016\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E2\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E3\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E302\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E316\u003C\/span\u003E.e8.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/j.jcmgh.2015.12.005\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DCell%2BMol%2BGastroenterol%2BHepatol%26rft.volume%253D2%26rft.spage%253D302%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jcmgh.2015.12.005%26rft_id%253Dinfo%253Apmid%252F28090562%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.jcmgh.2015.12.005\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=28090562\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E17.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2025.02.17.25321289v1.17\u0022 data-doi=\u002210.1111\/jvh.12488\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDultz\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGerber\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZeuzem\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESarrazin\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWaidmann\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EO\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EThe macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Viral Hepat\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EApr\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2016\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E23\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E4\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E267\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E73\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1111\/jvh.12488\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BViral%2BHepat%26rft.volume%253D23%26rft.spage%253D267%26rft_id%253Dinfo%253Adoi%252F10.1111%252Fjvh.12488%26rft_id%253Dinfo%253Apmid%252F26554542%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1111\/jvh.12488\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=26554542\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E18.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2025.02.17.25321289v1.18\u0022 data-doi=\u002210.3389\/fimmu.2022.832206\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EOsuch\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELaskus\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPerlejewski\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ECD8\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EFront Immunol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E13\u003C\/span\u003E:\u003Cspan class=\u0022cit-issue\u0022\u003E832206\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3389\/fimmu.2022.832206\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DFront%2BImmunol%26rft_id%253Dinfo%253Adoi%252F10.3389%252Ffimmu.2022.832206%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3389\/fimmu.2022.832206\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E19.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-19-1\u0022 title=\u0022View reference 19. in text\u0022 id=\u0022ref-19\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.19\u0022 data-doi=\u002210.1038\/s41467-019-14137-7\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBarili\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EV\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EFisicaro\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMontanini\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ETargeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENat Commun\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EJan\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E30\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E11\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E604\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/s41467-019-14137-7\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNat%2BCommun%26rft.volume%253D11%26rft.spage%253D604%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fs41467-019-14137-7%26rft_id%253Dinfo%253Apmid%252F32001678%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/s41467-019-14137-7\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=32001678\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E20.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-20-1\u0022 title=\u0022View reference 20. in text\u0022 id=\u0022ref-20\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.20\u0022 data-doi=\u002210.1007\/s12072-018-9896-4\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAbutaleb\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESherman\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EKE\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EA changing paradigm: management and treatment of the HCV\/HIV-co-infected patient\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EHepatol Int\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ENov\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2018\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E12\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E6\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E500\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E509\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1007\/s12072-018-9896-4\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DHepatol%2BInt%26rft.volume%253D12%26rft.spage%253D500%26rft_id%253Dinfo%253Adoi%252F10.1007%252Fs12072-018-9896-4%26rft_id%253Dinfo%253Apmid%252F30238230%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1007\/s12072-018-9896-4\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=30238230\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E21.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-21-1\u0022 title=\u0022View reference 21. in text\u0022 id=\u0022ref-21\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.21\u0022 data-doi=\u002210.1080\/00365521.2018.1481996\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003ELund\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ELaursen T\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E \u003Cspan class=\u0022cit-name-given-names\u0022\u003EBr\u00f8ckner\u003C\/span\u003E \u003Cspan class=\u0022cit-name-surname\u0022\u003ESiggard C\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKazankov\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ERapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EScand J Gastroenterol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EAug\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2018\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E53\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E8\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E986\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E993\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1080\/00365521.2018.1481996\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DScand%2BJ%2BGastroenterol%26rft.volume%253D53%26rft.spage%253D986%26rft_id%253Dinfo%253Adoi%252F10.1080%252F00365521.2018.1481996%26rft_id%253Dinfo%253Apmid%252F29987961%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1080\/00365521.2018.1481996\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=29987961\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E22.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-22-1\u0022 title=\u0022View reference 22. in text\u0022 id=\u0022ref-22\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.22\u0022 data-doi=\u002210.1016\/j.jhep.2014.05.043\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMartin\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHennecke\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EN\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELohmann\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EV\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ERestoration of HCV-specific CD8+ T cell function by interferon-free therapy\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Hepatol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ESep\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E61\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E3\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E538\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E43\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/j.jhep.2014.05.043\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BHepatol%26rft.volume%253D61%26rft.spage%253D538%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jhep.2014.05.043%26rft_id%253Dinfo%253Apmid%252F24905492%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.jhep.2014.05.043\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=24905492\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E23.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-23-1\u0022 title=\u0022View reference 23. in text\u0022 id=\u0022ref-23\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.23\u0022 data-doi=\u002210.1111\/his.13453\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPutra\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESchiano\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ETD\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EFiel\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMI\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EHistological assessment of the liver explant in transplanted hepatitis C virus patients achieving sustained virological response with direct-acting antiviral agents\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EHistopathology\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EMay\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2018\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E72\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E6\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E990\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E996\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1111\/his.13453\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DHistopathology%26rft.volume%253D72%26rft.spage%253D990%26rft_id%253Dinfo%253Adoi%252F10.1111%252Fhis.13453%26rft_id%253Dinfo%253Apmid%252F29235144%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1111\/his.13453\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=29235144\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E24.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-24-1\u0022 title=\u0022View reference 24. in text\u0022 id=\u0022ref-24\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.24\u0022 data-doi=\u002210.1097\/JCMA.0000000000000517\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHsieh\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EYC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELee\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EKC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESu\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECW\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EPersistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Chin Med Assoc\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EMay\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E01\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E84\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E5\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E472\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E477\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1097\/JCMA.0000000000000517\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BChin%2BMed%2BAssoc%26rft.volume%253D84%26rft.spage%253D472%26rft_id%253Dinfo%253Adoi%252F10.1097%252FJCMA.0000000000000517%26rft_id%253Dinfo%253Apmid%252F33742989%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1097\/JCMA.0000000000000517\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=33742989\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E25.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-25-1\u0022 title=\u0022View reference 25. in text\u0022 id=\u0022ref-25\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.25\u0022 data-doi=\u002210.1038\/s41598-021-93881-7\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESaldarriaga\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EOA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDye\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPham\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EComparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ESci Rep\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EJul\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E15\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E11\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E14506\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/s41598-021-93881-7\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DSci%2BRep%26rft.volume%253D11%26rft.spage%253D14506%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fs41598-021-93881-7%26rft_id%253Dinfo%253Apmid%252F34267267%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/s41598-021-93881-7\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=34267267\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E26.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-26-1\u0022 title=\u0022View reference 26. in text\u0022 id=\u0022ref-26\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.26\u0022 data-doi=\u002210.1016\/j.cgh.2017.04.041\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWhitcomb\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EChoi\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EWT\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EJerome\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EKR\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EBiopsy Specimens From Allograft Liver Contain Histologic Features of Hepatitis C Virus Infection After Virus Eradication\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EClin Gastroenterol Hepatol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EAug\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2017\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E15\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E8\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E1279\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1285\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/j.cgh.2017.04.041\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DClin%2BGastroenterol%2BHepatol%26rft.volume%253D15%26rft.spage%253D1279%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cgh.2017.04.041%26rft_id%253Dinfo%253Apmid%252F28501538%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.cgh.2017.04.041\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=28501538\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E27.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-27-1\u0022 title=\u0022View reference 27. in text\u0022 id=\u0022ref-27\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.27\u0022 data-doi=\u002210.3390\/cells11213387\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELee\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKim\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECha\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EMultiplexed Digital Spatial Protein Profiling Reveals Distinct Phenotypes of Mononuclear Phagocytes in Livers with Advanced Fibrosis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ECells\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EOct\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E26\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E11\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E21\u003C\/span\u003E)\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3390\/cells11213387\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DCells%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fcells11213387%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3390\/cells11213387\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E28.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-28-1\u0022 title=\u0022View reference 28. in text\u0022 id=\u0022ref-28\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.28\u0022 data-doi=\u002210.1038\/s41467-018-06318-7\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMacParland\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ESA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELiu\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMa\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EXZ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ESingle cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENat Commun\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-day\u0022\u003E10\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2018\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E9\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E4383\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/s41467-018-06318-7\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNat%2BCommun%26rft.volume%253D9%26rft.spage%253D4383%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fs41467-018-06318-7%26rft_id%253Dinfo%253Apmid%252F30348985%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/s41467-018-06318-7\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=30348985\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E29.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-29-1\u0022 title=\u0022View reference 29. in text\u0022 id=\u0022ref-29\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.29\u0022 data-doi=\u002210.1093\/cid\/ciad319\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBhattacharya\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAronsohn\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPrice\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELo Re\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EV\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPanel\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA-IHG\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EHepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EClin Infect Dis\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EMay\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E25\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2023\u003C\/span\u003E;\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1093\/cid\/ciad319\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DClin%2BInfect%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fcid%252Fciad319%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1093\/cid\/ciad319\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E30.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-30-1\u0022 title=\u0022View reference 30. in text\u0022 id=\u0022ref-30\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.30\u0022 data-doi=\u002210.1016\/0168-8278(95)80226-6\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EIshak\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBaptista\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBianchi\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EHistological grading and staging of chronic hepatitis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Hepatol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EJun\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E1995\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E22\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E6\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E696\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E9\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/0168-8278(95)80226-6\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bhepatology%26rft.stitle%253DJ%2BHepatol%26rft.aulast%253DIshak%26rft.auinit1%253DK.%26rft.volume%253D22%26rft.issue%253D6%26rft.spage%253D696%26rft.epage%253D699%26rft.atitle%253DHistological%2Bgrading%2Band%2Bstaging%2Bof%2Bchronic%2Bhepatitis.%26rft_id%253Dinfo%253Adoi%252F10.1016%252F0168-8278%252895%252980226-6%26rft_id%253Dinfo%253Apmid%252F7560864%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/0168-8278(95)80226-6\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=7560864\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=A1995RL11500012\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E31.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2025.02.17.25321289v1.31\u0022 data-doi=\u002210.1002\/hep.1840010511\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKnodell\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ERG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EIshak\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EKG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBlack\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EWC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EFormulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EHepatology\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E1981\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E1\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E5\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E431\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E5\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1002\/hep.1840010511\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DHepatology%2B%2528Baltimore%252C%2BMd.%2529%26rft.stitle%253DHepatology%26rft.aulast%253DKnodell%26rft.auinit1%253DR.%26rft.volume%253D1%26rft.issue%253D5%26rft.spage%253D431%26rft.epage%253D435%26rft.atitle%253DFormulation%2Band%2Bapplication%2Bof%2Ba%2Bnumerical%2Bscoring%2Bsystem%2Bfor%2Bassessing%2Bhistological%2Bactivity%2Bin%2Basymptomatic%2Bchronic%2Bactive%2Bhepatitis%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fhep.1840010511%26rft_id%253Dinfo%253Apmid%252F7308988%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1002\/hep.1840010511\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=7308988\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=A1981MP48000010\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E32.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-32-1\u0022 title=\u0022View reference 32. in text\u0022 id=\u0022ref-32\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.32\u0022 data-doi=\u002210.1002\/hep.20701\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKleiner\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EDE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBrunt\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EEM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EVan Natta\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EDesign and validation of a histological scoring system for nonalcoholic fatty liver disease\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EHepatology\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EJun\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2005\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E41\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E6\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E1313\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E21\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DHepatology%2B%2528Baltimore%252C%2BMd.%2529%26rft.stitle%253DHepatology%26rft.aulast%253DKleiner%26rft.auinit1%253DD.%2BE.%26rft.volume%253D41%26rft.issue%253D6%26rft.spage%253D1313%26rft.epage%253D1321%26rft.atitle%253DDesign%2Band%2Bvalidation%2Bof%2Ba%2Bhistological%2Bscoring%2Bsystem%2Bfor%2Bnonalcoholic%2Bfatty%2Bliver%2Bdisease.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fhep.20701%26rft_id%253Dinfo%253Apmid%252F15915461%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1002\/hep.20701\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=15915461\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000229517300014\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E33.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-33-1\u0022 title=\u0022View reference 33. in text\u0022 id=\u0022ref-33\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.33\u0022 data-doi=\u002210.1016\/j.cancergen.2022.10.143\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZheng\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPiao\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EXM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EByun\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EYJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EStudy on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ECancer Genet\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ENov\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E;\u003Cspan class=\u0022cit-fpage\u0022\u003E268\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E269\u003C\/span\u003E:137-143.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/j.cancergen.2022.10.143\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DCancer%2BGenet%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.cancergen.2022.10.143%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.cancergen.2022.10.143\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E34.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-34-1\u0022 title=\u0022View reference 34. in text\u0022 id=\u0022ref-34\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.34\u0022 data-doi=\u002210.1038\/nprot.2008.211\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHuang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EdW\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESherman\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EBT\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELempicki\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ERA\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003ESystematic and integrative analysis of large gene lists using DAVID bioinformatics resources\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENat Protoc\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2009\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E4\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E44\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E57\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/nprot.2008.211\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.stitle%253DNat%2BProtoc%26rft.aulast%253DHuang%26rft.auinit1%253Dd.%2Ba.%2B%2B.%2BW.%26rft.volume%253D4%26rft.issue%253D1%26rft.spage%253D44%26rft.epage%253D57%26rft.atitle%253DSystematic%2Band%2Bintegrative%2Banalysis%2Bof%2Blarge%2Bgene%2Blists%2Busing%2BDAVID%2Bbioinformatics%2Bresources.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnprot.2008.211%26rft_id%253Dinfo%253Apmid%252F19131956%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/nprot.2008.211\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=19131956\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000265781800006\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E35.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-35-1\u0022 title=\u0022View reference 35. in text\u0022 id=\u0022ref-35\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.35\u0022 data-doi=\u002210.1007\/978-1-4939-7493-1_12\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EChen\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKhodadoust\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMS\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELiu\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ENewman\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAlizadeh\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAA\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EProfiling Tumor Infiltrating Immune Cells with CIBERSORT\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EMethods Mol Biol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2018\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E1711\u003C\/span\u003E:\u003Cspan class=\u0022cit-fpage\u0022\u003E243\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E259\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1007\/978-1-4939-7493-1_12\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DMethods%2BMol%2BBiol%26rft.volume%253D1711%26rft.spage%253D243%26rft_id%253Dinfo%253Adoi%252F10.1007%252F978-1-4939-7493-1_12%26rft_id%253Dinfo%253Apmid%252F29344893%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1007\/978-1-4939-7493-1_12\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=29344893\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E36.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-36-1\u0022 title=\u0022View reference 36. in text\u0022 id=\u0022ref-36\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.36\u0022 data-doi=\u002210.1016\/j.jhepr.2023.100958\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESaldarriaga\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EOA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWanninger\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ETG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EArroyave\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EHeterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJHEP Rep\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EJan\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2024\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E6\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E100958\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/j.jhepr.2023.100958\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJHEP%2BRep%26rft.volume%253D6%26rft.spage%253D100958%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jhepr.2023.100958%26rft_id%253Dinfo%253Apmid%252F38162144%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.jhepr.2023.100958\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=38162144\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E37.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-37-1\u0022 title=\u0022View reference 37. in text\u0022 id=\u0022ref-37\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.37\u0022 data-doi=\u002210.15252\/emmm.201607006\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBoldanova\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESuslov\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHeim\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ENecsulea\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003ETranscriptional response to hepatitis C virus infection and interferon-alpha treatment in the human liver\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EEMBO Mol Med\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EJun\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2017\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E9\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E6\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E816\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E834\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.15252\/emmm.201607006\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DEMBO%2BMol%2BMed%26rft_id%253Dinfo%253Adoi%252F10.15252%252Femmm.201607006%26rft_id%253Dinfo%253Apmid%252F28360091%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NjoiZW1ib21tIjtzOjU6InJlc2lkIjtzOjc6IjkvNi84MTYiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyNS8wMi8xOC8yMDI1LjAyLjE3LjI1MzIxMjg5LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E38.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-38-1\u0022 title=\u0022View reference 38. in text\u0022 id=\u0022ref-38\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.38\u0022 data-doi=\u002210.1016\/j.jhep.2014.06.035\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHeim\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EThimme\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EInnate and adaptive immune responses in HCV infections\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Hepatol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ENov\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E61\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E1 Suppl\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003ES14\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E25\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/j.jhep.2014.06.035\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BHepatol%26rft.volume%253D61%26rft.spage%253DS14%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jhep.2014.06.035%26rft_id%253Dinfo%253Apmid%252F25443342%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.jhep.2014.06.035\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=25443342\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E39.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-39-1\u0022 title=\u0022View reference 39. in text\u0022 id=\u0022ref-39\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.39\u0022 data-doi=\u002210.1371\/journal.ppat.1009799\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBurchill\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESalomon\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMP\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGolden-Mason\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ESingle-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EPLoS Pathog\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EAug\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E17\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E8\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003Ee1009799\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1371\/journal.ppat.1009799\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DPLoS%2BPathog%26rft.volume%253D17%26rft.spage%253De1009799%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.ppat.1009799%26rft_id%253Dinfo%253Apmid%252F34370798%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1371\/journal.ppat.1009799\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=34370798\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E40.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-40-1\u0022 title=\u0022View reference 40. in text\u0022 id=\u0022ref-40\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.40\u0022 data-doi=\u002210.1186\/s12885-022-09388-5\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHuang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZhou\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ENie\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGuo\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZhu\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EX\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EA new finding in the key prognosis-related proto-oncogene FYN in hepatocellular carcinoma based on the WGCNA hub-gene screening trategy\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EBMC Cancer\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EApr\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E09\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E22\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E380\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1186\/s12885-022-09388-5\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DBMC%2BCancer%26rft.volume%253D22%26rft.spage%253D380%26rft_id%253Dinfo%253Adoi%252F10.1186%252Fs12885-022-09388-5%26rft_id%253Dinfo%253Apmid%252F35397600%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1186\/s12885-022-09388-5\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=35397600\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E41.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2025.02.17.25321289v1.41\u0022 data-doi=\u002210.1038\/cddis.2014.392\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELin\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHan\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EXu\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ELL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EYu\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EHX\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EYang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EPY\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003ECXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ECell Death Dis\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EOct\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E23\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E5\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E10\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003Ee1488\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/cddis.2014.392\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DCell%2BDeath%2BDis%26rft.volume%253D5%26rft.spage%253De1488%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fcddis.2014.392%26rft_id%253Dinfo%253Apmid%252F25341042%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/cddis.2014.392\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=25341042\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E42.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-42-1\u0022 title=\u0022View reference 42. in text\u0022 id=\u0022ref-42\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.42\u0022 data-doi=\u002210.3390\/curroncol28040264\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHosseini-Khah\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EZ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBabaei\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMR\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETehrani\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ESOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ECurr Oncol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EAug\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E09\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E28\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E4\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E3015\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E3029\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3390\/curroncol28040264\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DCurr%2BOncol%26rft.volume%253D28%26rft.spage%253D3015%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fcurroncol28040264%26rft_id%253Dinfo%253Apmid%252F34436030%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3390\/curroncol28040264\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=34436030\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E43.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-43-1\u0022 title=\u0022View reference 43. in text\u0022 id=\u0022ref-43\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.43\u0022 data-doi=\u002210.1002\/hep4.1494\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESaldarriaga\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EOA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EFreiberg\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKrishnan\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EMultispectral Imaging Enables Characterization of Intrahepatic Macrophages in Patients With Chronic Liver Disease\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EHepatol Commun\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EMay\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E4\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E5\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E708\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E723\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1002\/hep4.1494\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DHepatol%2BCommun%26rft.volume%253D4%26rft.spage%253D708%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fhep4.1494%26rft_id%253Dinfo%253Apmid%252F32363321%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1002\/hep4.1494\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=32363321\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E44.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-44-1\u0022 title=\u0022View reference 44. in text\u0022 id=\u0022ref-44\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.44\u0022 data-doi=\u002210.1371\/journal.pone.0171755\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWelsch\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EEfinger\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003Evon Wagner\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EOngoing liver inflammation in patients with chronic hepatitis C and sustained virological response\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EPLoS One\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2017\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E12\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003Ee0171755\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1371\/journal.pone.0171755\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DPLoS%2BOne%26rft.volume%253D12%26rft.spage%253De0171755%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0171755%26rft_id%253Dinfo%253Apmid%252F28196130%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1371\/journal.pone.0171755\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=28196130\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E45.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-45-1\u0022 title=\u0022View reference 45. in text\u0022 id=\u0022ref-45\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.45\u0022 data-doi=\u002210.1053\/j.gastro.2009.09.009\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETu\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EZ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPierce\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ERH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKurtis\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKuroki\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECrispe\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EIN\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EOrloff\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMS\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EHepatitis C virus core protein subverts the antiviral activities of human Kupffer cells\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EGastroenterology\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EJan\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2010\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E138\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E305\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E14\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1053\/j.gastro.2009.09.009\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.stitle%253DGastroenterology%26rft.aulast%253DTu%26rft.auinit1%253DZ.%26rft.volume%253D138%26rft.issue%253D1%26rft.spage%253D305%26rft.epage%253D314%26rft.atitle%253DHepatitis%2BC%2Bvirus%2Bcore%2Bprotein%2Bsubverts%2Bthe%2Bantiviral%2Bactivities%2Bof%2Bhuman%2BKupffer%2Bcells.%26rft_id%253Dinfo%253Adoi%252F10.1053%252Fj.gastro.2009.09.009%26rft_id%253Dinfo%253Apmid%252F19769973%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1053\/j.gastro.2009.09.009\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=19769973\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000273427700040\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E46.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2025.02.17.25321289v1.46\u0022 data-doi=\u002210.3892\/etm.2022.11448\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZhao\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESi\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDeng\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EX\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ED\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKong\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZhang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EQ\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EHCV inhibits M2a, M2b and M2c macrophage polarization via HCV core protein engagement with Toll-like receptor 2\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EExp Ther Med\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EAug\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E24\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E522\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3892\/etm.2022.11448\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DExp%2BTher%2BMed%26rft.volume%253D24%26rft.spage%253D522%26rft_id%253Dinfo%253Adoi%252F10.3892%252Fetm.2022.11448%26rft_id%253Dinfo%253Apmid%252F35837038%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3892\/etm.2022.11448\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=35837038\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E47.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-47-1\u0022 title=\u0022View reference 47. in text\u0022 id=\u0022ref-47\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.47\u0022 data-doi=\u002210.3389\/fimmu.2019.01926\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EVranjkovic\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDeonarine\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKaka\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAngel\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJB\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECooper\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECrawley\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAM\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EDirect-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EFront Immunol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2019\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E10\u003C\/span\u003E:\u003Cspan class=\u0022cit-fpage\u0022\u003E1926\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3389\/fimmu.2019.01926\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DFront%2BImmunol%26rft.volume%253D10%26rft.spage%253D1926%26rft_id%253Dinfo%253Adoi%252F10.3389%252Ffimmu.2019.01926%26rft_id%253Dinfo%253Apmid%252F31456810%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3389\/fimmu.2019.01926\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=31456810\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E48.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-48-1\u0022 title=\u0022View reference 48. in text\u0022 id=\u0022ref-48\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.48\u0022 data-doi=\u002210.1053\/j.gastro.2004.09.014\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EFattovich\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EStroffolini\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EZagni\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EI\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDonato\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EHepatocellular carcinoma in cirrhosis: incidence and risk factors\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EGastroenterology\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ENov\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2004\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E127\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E5 Suppl 1\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003ES35\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E50\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1053\/j.gastro.2004.09.014\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DGastroenterology%26rft.stitle%253DGastroenterology%26rft.volume%253D127%26rft.spage%253DS35%26rft_id%253Dinfo%253Adoi%252F10.1053%252Fj.gastro.2004.09.014%26rft_id%253Dinfo%253Apmid%252F15508101%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1053\/j.gastro.2004.09.014\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=15508101\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000225156200005\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E49.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-49-1\u0022 title=\u0022View reference 49. in text\u0022 id=\u0022ref-49\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.49\u0022 data-doi=\u002210.1016\/S0140-6736(96)07642-8\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPoynard\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBedossa\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EOpolon\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003ENatural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ELancet\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EMar\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E22\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E1997\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E349\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E9055\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E825\u003C\/span\u003E-\u003Cspan class=\u0022cit-lpage\u0022\u003E32\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/s0140-6736(96)07642-8\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DPoynard%26rft.auinit1%253DT.%26rft.volume%253D349%26rft.issue%253D9055%26rft.spage%253D825%26rft.epage%253D832%26rft.atitle%253DNatural%2Bhistory%2Bof%2Bliver%2Bfibrosis%2Bprogression%2Bin%2Bpatients%2Bwith%2Bchronic%2Bhepatitis%2BC.%2BThe%2BOBSVIRC%252C%2BMETAVIR%252C%2BCLINIVIR%252C%2Band%2BDOSVIRC%2Bgroups.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252896%252907642-8%26rft_id%253Dinfo%253Apmid%252F9121257%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/S0140-6736(96)07642-8\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=9121257\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=A1997WP40300010\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E50.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-50-1\u0022 title=\u0022View reference 50. in text\u0022 id=\u0022ref-50\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.50\u0022 data-doi=\u002210.3390\/cancers14081861\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMillian\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EDE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESaldarriaga\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EOA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWanninger\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ECutting-Edge Platforms for Analysis of Immune Cells in the Hepatic Microenvironment-Focus on Tumor-Associated Macrophages in Hepatocellular Carcinoma\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ECancers (Basel)\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EApr\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E07\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E14\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E8\u003C\/span\u003E)\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3390\/cancers14081861\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DCancers%2B%2528Basel%2529%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fcancers14081861%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3390\/cancers14081861\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E51.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-51-1\u0022 title=\u0022View reference 51. in text\u0022 id=\u0022ref-51\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.51\u0022 data-doi=\u002210.1002\/hep.25606\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ED\u2019Ambrosio\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAghemo\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERumi\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EA morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EHepatology\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EAug\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E56\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E532\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E43\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1002\/hep.25606\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DHepatology%2B%2528Baltimore%252C%2BMd.%2529%26rft.stitle%253DHepatology%26rft.aulast%253DD%2527Ambrosio%26rft.auinit1%253DR.%26rft.volume%253D56%26rft.issue%253D2%26rft.spage%253D532%26rft.epage%253D543%26rft.atitle%253DA%2Bmorphometric%2Band%2Bimmunohistochemical%2Bstudy%2Bto%2Bassess%2Bthe%2Bbenefit%2Bof%2Ba%2Bsustained%2Bvirological%2Bresponse%2Bin%2Bhepatitis%2BC%2Bvirus%2Bpatients%2Bwith%2Bcirrhosis.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fhep.25606%26rft_id%253Dinfo%253Apmid%252F22271347%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1002\/hep.25606\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=22271347\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000306804500017\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E52.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-52-1\u0022 title=\u0022View reference 52. in text\u0022 id=\u0022ref-52\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.52\u0022 data-doi=\u002210.1038\/srep39520\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBility\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMT\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ENio\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELi\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EChronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activation\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ESci Rep\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EDec\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E21\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2016\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E6\u003C\/span\u003E:\u003Cspan class=\u0022cit-issue\u0022\u003E39520\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/srep39520\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DSci%2BRep%26rft.volume%253D6%26rft.spage%253D39520%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fsrep39520%26rft_id%253Dinfo%253Apmid%252F28000758%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/srep39520\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=28000758\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E53.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-53-1\u0022 title=\u0022View reference 53. in text\u0022 id=\u0022ref-53\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.53\u0022 data-doi=\u002210.1016\/j.jhepr.2022.100560\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EListopad\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMagnan\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAsghar\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EDifferentiating between liver diseases by applying multiclass machine learning approaches to transcriptomics of liver tissue or blood-based samples\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJHEP Rep\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EOct\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E4\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E10\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E100560\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/j.jhepr.2022.100560\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJHEP%2BRep%26rft.volume%253D4%26rft.spage%253D100560%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jhepr.2022.100560%26rft_id%253Dinfo%253Apmid%252F36119721%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.jhepr.2022.100560\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=36119721\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E54.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2025.02.17.25321289v1.54\u0022 data-doi=\u002210.1111\/jvh.13041\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHolmes\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECarlton-Smith\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKim\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAY\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EDynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Viral Hepat\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EMar\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2019\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E26\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E3\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E362\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E372\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1111\/jvh.13041\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BViral%2BHepat%26rft.volume%253D26%26rft.spage%253D362%26rft_id%253Dinfo%253Adoi%252F10.1111%252Fjvh.13041%26rft_id%253Dinfo%253Apmid%252F30450781%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1111\/jvh.13041\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=30450781\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E55.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-55-1\u0022 title=\u0022View reference 55. in text\u0022 id=\u0022ref-55\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.55\u0022 data-doi=\u002210.1016\/j.jhep.2023.02.040\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECui\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELi\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWallace\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMS\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ESingle-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Hepatol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EFeb\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2024\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E80\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E2\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E251\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E267\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/j.jhep.2023.02.040\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BHepatol%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jhep.2023.02.040%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.jhep.2023.02.040\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E56.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-56-1\u0022 title=\u0022View reference 56. in text\u0022 id=\u0022ref-56\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.56\u0022 data-doi=\u002210.1371\/journal.ppat.1003330\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ENegash\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERamos\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EHJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECrochet\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EN\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EIL-1\u03b2 production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EPLoS Pathog\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2013\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E9\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E4\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003Ee1003330\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1371\/journal.ppat.1003330\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DPLoS%2BPathog%26rft.volume%253D9%26rft.spage%253De1003330%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.ppat.1003330%26rft_id%253Dinfo%253Apmid%252F23633957%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1371\/journal.ppat.1003330\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=23633957\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E57.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-57-1\u0022 title=\u0022View reference 57. in text\u0022 id=\u0022ref-57\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.57\u0022 data-doi=\u002210.1128\/JVI.00775-14\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHou\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003Evan Oord\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGroothuismink\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EZM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EGene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic hepatitis C virus infection\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Virol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ENov\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E88\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E21\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E12254\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E64\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1128\/JVI.00775-14\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJ%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.00775-14%26rft_id%253Dinfo%253Apmid%252F25100847%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI4OC8yMS8xMjI1NCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDI1LzAyLzE4LzIwMjUuMDIuMTcuMjUzMjEyODkuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E58.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-58-1\u0022 title=\u0022View reference 58. in text\u0022 id=\u0022ref-58\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.58\u0022 data-doi=\u002210.1038\/ncomms6699\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETerczy\u0144ska-Dyla\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBibert\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDuong\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EFH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EReduced IFN\u03bb4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENat Commun\u003C\/abbr\u003E \u003Cspan class=\u0022cit-month\u0022\u003EDec\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E23\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E5\u003C\/span\u003E:\u003Cspan class=\u0022cit-fpage\u0022\u003E5699\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/ncomms6699\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNat%2BCommun%26rft.volume%253D5%26rft.spage%253D5699%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fncomms6699%26rft_id%253Dinfo%253Apmid%252F25534433%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/ncomms6699\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=25534433\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E59.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-59-1\u0022 title=\u0022View reference 59. in text\u0022 id=\u0022ref-59\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.59\u0022 data-doi=\u002210.1016\/j.gendis.2019.05.004\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESalum\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EGM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDawood\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ERM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAbd El-Meguid\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EIbrahim\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ENE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAbdel Aziz\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAO\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EEl Awady\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMK\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003ECorrelation between IL28B\/TLR4 genetic variants and HCC development with\/without DAAs treatment in chronic HCV patients\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EGenes Dis\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ESep\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E7\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E3\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E392\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E400\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1016\/j.gendis.2019.05.004\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DGenes%2BDis%26rft.volume%253D7%26rft.spage%253D392%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.gendis.2019.05.004%26rft_id%253Dinfo%253Apmid%252F32884993%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/j.gendis.2019.05.004\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=32884993\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E60.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-60-1\u0022 title=\u0022View reference 60. in text\u0022 id=\u0022ref-60\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.60\u0022 data-doi=\u002210.1038\/s41598-020-73137-6\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EOsuch\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELaskus\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBerak\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EDecrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ESci Rep\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ESep\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E29\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E10\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E1\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E16060\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1038\/s41598-020-73137-6\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DSci%2BRep%26rft.volume%253D10%26rft.spage%253D16060%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fs41598-020-73137-6%26rft_id%253Dinfo%253Apmid%252F32994477%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1038\/s41598-020-73137-6\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=32994477\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E61.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-61-1\u0022 title=\u0022View reference 61. in text\u0022 id=\u0022ref-61\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.61\u0022 data-doi=\u002210.1002\/eji.201646447\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHengst\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EStrunz\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EB\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDeterding\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ENonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EEur J Immunol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003ESep\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2016\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E46\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E9\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E2204\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E10\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1002\/eji.201646447\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DEur%2BJ%2BImmunol%26rft.volume%253D46%26rft.spage%253D2204%26rft_id%253Dinfo%253Adoi%252F10.1002%252Feji.201646447%26rft_id%253Dinfo%253Apmid%252F27296288%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1002\/eji.201646447\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=27296288\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E62.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-62-1\u0022 title=\u0022View reference 62. in text\u0022 id=\u0022ref-62\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.62\u0022 data-doi=\u002210.1182\/blood-2010-12-322453\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECorbeau\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EP\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EReynes\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EImmune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EBlood\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EMay\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E26\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2011\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E117\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E21\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E5582\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E90\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1182\/blood-2010-12-322453\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DBlood%26rft_id%253Dinfo%253Adoi%252F10.1182%252Fblood-2010-12-322453%26rft_id%253Dinfo%253Apmid%252F21403129%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTI6ImJsb29kam91cm5hbCI7czo1OiJyZXNpZCI7czoxMToiMTE3LzIxLzU1ODIiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyNS8wMi8xOC8yMDI1LjAyLjE3LjI1MzIxMjg5LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E63.\u003C\/span\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal no-rev-xref\u0022 id=\u0022cit-2025.02.17.25321289v1.63\u0022 data-doi=\u002210.1086\/695852\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGazzola\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETincati\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBellistr\u00ec\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EGM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMonforte\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMarchetti\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EThe absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EClin Infect Dis\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EFeb\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E01\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2009\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E48\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E3\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E328\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E37\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1086\/595851\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DClin%2BInfect%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1086%252F695852%26rft_id%253Dinfo%253Apmid%252F19123868%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1086\/695852\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=19123868\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000262291200010\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E64.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-64-1\u0022 title=\u0022View reference 64. in text\u0022 id=\u0022ref-64\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.64\u0022 data-doi=\u002210.1371\/journal.pmed.1001194\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EYoung\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPsichogiou\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMeyer\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ECD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EPLoS Med\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E9\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E3\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003Ee1001194\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1371\/journal.pmed.1001194\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.stitle%253DPLoS%2BMed%26rft.volume%253D9%26rft.issue%253D3%26rft.spage%253De1001194%26rft.epage%253De1001194%26rft.atitle%253DCD4%2Bcell%2Bcount%2Band%2Bthe%2Brisk%2Bof%2BAIDS%2Bor%2Bdeath%2Bin%2BHIV-Infected%2Badults%2Bon%2Bcombination%2Bantiretroviral%2Btherapy%2Bwith%2Ba%2Bsuppressed%2Bviral%2Bload%253A%2Ba%2Blongitudinal%2Bcohort%2Bstudy%2Bfrom%2BCOHERE.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pmed.1001194%26rft_id%253Dinfo%253Apmid%252F22448150%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1371\/journal.pmed.1001194\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=22448150\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=22448150\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E65.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-65-1\u0022 title=\u0022View reference 65. in text\u0022 id=\u0022ref-65\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.65\u0022 data-doi=\u002210.3389\/fimmu.2021.723196\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBrochado-Kith\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003E\u00d3\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMart\u00ednez\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EI\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBerenguer\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EHCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV\/HCV-Coinfected Patients\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EFront Immunol\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E12\u003C\/span\u003E:\u003Cspan class=\u0022cit-issue\u0022\u003E723196\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3389\/fimmu.2021.723196\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DFront%2BImmunol%26rft_id%253Dinfo%253Adoi%252F10.3389%252Ffimmu.2021.723196%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3389\/fimmu.2021.723196\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E66.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-66-1\u0022 title=\u0022View reference 66. in text\u0022 id=\u0022ref-66\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.66\u0022 data-doi=\u002210.3389\/fmed.2021.615342\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMedrano\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ELM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBerenguer\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESalg\u00fcero\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ESuccessful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV\/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EFront Med (Lausanne\u003C\/abbr\u003E\u003Cem\u003E)\u003C\/em\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E8\u003C\/span\u003E:\u003Cspan class=\u0022cit-issue\u0022\u003E615342\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3389\/fmed.2021.615342\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DFront%2BMed%2B%2528Lausanne%26rft_id%253Dinfo%253Adoi%252F10.3389%252Ffmed.2021.615342%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3389\/fmed.2021.615342\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E67.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-67-1\u0022 title=\u0022View reference 67. in text\u0022 id=\u0022ref-67\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.67\u0022 data-doi=\u002210.1371\/journal.pone.0039576\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBeynon\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EV\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EQuintana\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EFJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWeiner\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EHL\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EActivated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EPLoS One\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E7\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E6\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003Ee39576\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1371\/journal.pone.0039576\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.stitle%253DPLoS%2BONE%26rft.aulast%253DBeynon%26rft.auinit1%253DV.%26rft.volume%253D7%26rft.issue%253D6%26rft.spage%253De39576%26rft.epage%253De39576%26rft.atitle%253DActivated%2Bhuman%2BCD4%252BCD45RO%252B%2Bmemory%2BT-cells%2Bindirectly%2Binhibit%2BNLRP3%2Binflammasome%2Bactivation%2Bthrough%2Bdownregulation%2Bof%2BP2X7R%2Bsignalling.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0039576%26rft_id%253Dinfo%253Apmid%252F22768094%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1371\/journal.pone.0039576\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=22768094\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E68.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-68-1\u0022 title=\u0022View reference 68. in text\u0022 id=\u0022ref-68\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.68\u0022 data-doi=\u002210.3390\/cancers15112871\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESanchez\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJI\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EParra\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EER\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EJiao\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ECellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ECancers (Basel)\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EMay\u003C\/span\u003E \u003Cspan class=\u0022cit-day\u0022\u003E23\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2023\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E15\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E11\u003C\/span\u003E)\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3390\/cancers15112871\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DCancers%2B%2528Basel%2529%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fcancers15112871%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3390\/cancers15112871\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Cspan class=\u0022ref-label\u0022\u003E69.\u003C\/span\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-69-1\u0022 title=\u0022View reference 69. in text\u0022 id=\u0022ref-69\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2025.02.17.25321289v1.69\u0022 data-doi=\u002210.1002\/hep.30988\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDang\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EYeo\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EYH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EYasuda\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ECure With Interferon-Free Direct-Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma From Both East and West\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EHepatology\u003C\/abbr\u003E. \u003Cspan class=\u0022cit-month\u0022\u003EJun\u003C\/span\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2020\u003C\/span\u003E;\u003Cspan class=\u0022cit-vol\u0022\u003E71\u003C\/span\u003E(\u003Cspan class=\u0022cit-issue\u0022\u003E6\u003C\/span\u003E):\u003Cspan class=\u0022cit-fpage\u0022\u003E1910\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E1922\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003Edoi:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1002\/hep.30988\u003C\/span\u003E\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DHepatology%26rft.volume%253D71%26rft.spage%253D1910%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fhep.30988%26rft_id%253Dinfo%253Apmid%252F31610027%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1002\/hep.30988\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=31610027\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2025%2F02%2F18%2F2025.02.17.25321289.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003C\/ol\u003E\u003C\/div\u003E\u003Cspan class=\u0022highwire-journal-article-marker-end\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003Cspan class=\u0022related-urls\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_zP7WWIfzbyzvaM63L39cNV2juU_1XVH7wduFK9gcMNI.js\u0022\u003E\u003C\/script\u003E\n\u003C\/body\u003E\u003C\/html\u003E"}